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ABSTRACT 
The requirement of new antimicrobial treatments has become an urgent field in the last two 
decades. Multi-drug resistant (MDR) bacteria are now resistant to common antibiotics such as 
penicillin, cephalosporin, and carbapenems. To antagonize such bacteria 8 novel 
organoantimony(V) cyanoximates were synthesized with the purpose to be characterized and 
submitted for biological activity studies. The eight organoantimony(V) cyanoximates were 
characterized by elemental analysis, thermal analysis, IR-, 13C{1H} NMR, some with UV-visible 
spectroscopy, and single crystal X-ray analysis. Eight new crystal structures were determined. 
All organoantimony(V) cyanoximates demonstrated a pentavalent coordinated distorted trigonal 
bipyramid polyhedron of the Sb(V) atom. Cyanoxime anionic ligands of each determined 
structure were bound to Sb(V) in a monodentate fashion. Antimicrobial Disk studies indicated 
that Sb(Ph)4(ACO), Sb(Ph)4(ECO), had significant antimicrobial effect against all three strains: 
two gram-negative a) Escherichia coli strain S17 and b) Pseudomonas aeruginosa strain PAO1, 
alongside a single gram-positive Methicillin-resistant Staphylococcus aureus strain NRS70. 
Sb(Ph)4(TCO) and Sb(Ph)4(TDCO) had significant effects on the gram- positive Methicillin-
resistant Staphylococcus aureus strain NRS70, but essentially no antimicrobial activity for gram-
negative strains used. Antimicrobial broth dilution MIC assays were completed against the same 
strains as antimicrobial disk studies but changed the compounds tested. Using Sb(Ph)4(MCO) as 
the only Sb(V) cyanoximate along with the free cyanoximes H(MCO), H(ECO), and 
Na[H(ACO)2]. Results indicated that free cyanoximes have no antimicrobial effect as the DMSO 
solvent used in these assays contributed to the inhibition factor to the MIC of the cell cultures. 
Antifungal disk assays concluded that Sb(Ph)4(ECO) was effective against Cryptococcus 
neoformans and Candida albicans in a positive trend. Sb(Ph)4(TCO) followed in antifungal 
activity against both strains. Sb(Ph)4(ACO) and Sb(Ph)4(TDCO) were only effective at inhibition 
of Cryptococcus neoformans. Antifungal MIC assays were conducted and concluded that the free 
cyanoximes had zero effect on antifungal activity against both fungi. On the other hand, 
Sb(Ph)4(MCO) had shown MIC levels ranging from 10 - 50 μg/mL. 
 
KEYWORDS:  cyanoximes, organoantimony(V), antimicrobial, antifungal, antibiotic-
resistance, X-ray single crystal analysis,   
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            Conducted work is dedicated to the synthesis and characterization of a series of novel 
organoantimony(V) compounds with oximes, and their biological activity evaluation as potential 
antimicrobial and antifungal treatments. 
 
I.1. Antibiotic Resistance 
            During a fifteen-year period in the 1930’s, the first clinical use of antibiotics, such as 
penicillin and sulfonamide, directly decreased the mortality rate from infections in the US by 
75%.1 Today, antibiotics are still the safety net between humans and harmful infections. The 
Centers for Disease Control and Prevention estimates that at least 23,000 people in the U.S. die 
annually by infections from antibiotic-resistance organisms.2 Gram-positive bacterial strains like 
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci 
(VRE) are gaining leverage over antibiotic treatment.3 Gram negative MDR bacteria pose a 
greater potential of resistance due to their multi-membrane structure, making them harder to 
treat.4 This resistance poses a great enough threat, that the World Health Organization (WHO) 
named antibiotic resistance as one of the three most important public health threats of the 
century.5 
            To be able to describe the mechanisms of antibiotic resistance, it is important to 
understand how antibiotics work. Antibiotics are synthesized in cells as a defense mechanism to 
compete against other cells for critical nutrients and other requirements needed for survival.6 
Antibiotic effects on cells can be divided into two types, bacteriostatic and bactericidal. The 
former stops growth and cell division, while the latter kills the cell completely. In either case, 
2 
antibiotics require a sufficient concentration to perform any antibiotic applications.6 In addition, 
antimicrobial resistance is ancient and is the result of various interactions between organisms and 
their environment. Most antimicrobial compounds are naturally produced molecules; therefore, 
bacteria have evolved mechanisms against such antimicrobials for survival.7 These organisms are 
coined intrinsically resistant and are not the focus of the antimicrobial resistance issue. Rather, 
bacteria that were originally susceptible of antibiotic treatment but then acquired resistance is the 
focus of this epidemic.  
 
I.2. Mechanisms Of Antibiotic Resistance 
            Antibiotic resistance can occur via two major genetic strategies by bacteria. The first 
strategy is acquisition of foreign DNA coding for resistance through horizontal gene transfer 
(HGT).7 Bacteria can acquire external genetic material through three situations, a) transformation 
(incorporation of naked DNA), b) transduction (phage mediated) and, c) conjugation (bacterial 
“sex”).7 The second strategy revolves around the mutations of gene(s) associated with the 
specific mechanism of action of the compound.7 These genetic mutations can alter the antibiotic 
action of following mechanisms resulting in antimicrobial-resistance. These mechanisms 
include, a) modifications of the antibiotic molecule, b) a decrease in drug uptake and increase of 
efflux, c) changes of target site and, d) global changes in important metabolic pathways via 
modulation of regulatory networks.6, 7 Each of these mechanisms will be further discussed below. 
           I.2.1. Modifications of the antibiotic molecule. This mechanism is one of the most 
successful bacterial strategies to fight against the presence of antibiotics. The organism produces 
enzymes that either inactivates the drug by adding specific chemical moieties to the antibiotic or 
complete destruction of the antibiotic itself.7 Both situations have the antibiotic unable to bind 
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with target site. In the case of chemical alterations, the production of enzymes that introduce 
chemical changes to the antibiotic is well-known mechanism used by gram-positive and gram-
negative bacteria. The chemical changes to these compounds are a result of enzyme-required 
biochemical reactions such as acetylation, phosphorylation, and adenylation.7, 8 The resulting 
effect is often correlated to steric hindrance, causing lower affinity of binding between the 
antibiotic and target site. The other modification of the antibiotic molecule pertains to the 
destruction of the antibiotic molecule. In the scenario of β-lactam antibiotic resistance (these 
include antibiotics such as penicillin derivatives, cephems, monobactams, carbapenems, and 
carbacephems) via β-lactamases, these enzymes destroy the amide bond of the β-lactam ring, 
inactivating the drug. 6, 9, 10 
           I.2.2. Decrease Of Drug Uptake And Increase Of Efflux. Most antibiotics have targets 
located inside the bacterial cell; therefore, the antibiotic compound must penetrate the outer 
and/or cytoplasmic membrane in order to use its antimicrobial effect.7 Bacteria have created a 
defense mechanism to prevent the uptake of antibiotics through the modification of porins. 
Porins are water diffusion channels that allow passage through the outer membrane of gram-
negative bacteria.11 Porin modifications that lead to a decrease in permeability, hence increasing 
antibiotic resistance include, a) shifts in the type of porins expressed, b) changes in level of porin 
expressed, and c) impairment of porin function. 7 If a bacterium has allowed antibiotic inside the 
cell, efflux pumps are used to extrude toxic compounds as a form of antibiotic resistance. One of 
the first efflux pumps described 12 a system with encoded plasmids, RP1, R222, R144, and RA1, 
used to facilitate extrusion of tetracycline out of E. coli. Since that study, many efflux pumps 
have been discovered and characterized in both gram-positive and gram-negative bacteria. These 
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systems can be substrate specific (i.e. tetracycline) or broad substrate specificity seen in MDR 
bacteria.7, 14 
I.2.3. Changes in target sites. This mechanism is a common strategy for bacteria to 
acquire resistance as it avoids the antimicrobial effect by interfering with the target site of the 
antibiotic. There are a couple pathways in which interreference of the target site can occur. The 
first pathway is through target protection. This protection is caused by inhibition of the target site 
with specific proteins used in elongation factors in protein synthesis 14 which “protects” the 
target site from the antibiotic. The second pathway modifies the target site to lower the affinity 
of binding between the antibiotic and target site. These target site changes include, a) point 
mutations in the genes encoding the target site, b) modification due to enzymatic reactions, c) 
replacement or bypass of the original target. 7 
I.2.4. Resistance due to global cell adaptations. The final mechanism discussed is 
developed by bacteria that need to cope with certain environmental stressors and pressures in 
order to survive hostile environments, such as the human body. If bacteria are inside host, the 
bacteria organisms are attacked by the hosts immune system. For these bacteria to survive, they 
need to adapt and cope with such stressful situations. These pathogens have created very 
complex mechanisms to remove the interference with crucial cellular processes like cell wall 
synthesis and membrane homeostasis.6, 7 
 
I.3. Further Complications With Antibiotic Resistance 
            The resistance of MDRs can also be attributed towards the environmental exposure 
caused by malpractice of qualified and unqualified medical practitioners and the patients that 
receive antibiotic treatment. Whether it is a physician prescribing antibiotic indiscriminately or 
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patients disobeying prescription plans, both lead to the increase of resistant microbes. The 
misuse of antibiotic treatment causes the exposure of more than 15 million kilograms of 
antibiotics annually in the US alone.4 
 Research and development for new antibiotic drugs have been terminated by most 
pharmaceutical companies.3 As a result, there has been a 90% decline in novel FDA approved 
antibiotics in the past 30 years.15 The emergence of bacterial antibiotic resistance is considered 
an epidemic. Suggested by a report, antibiotic resistance is estimated to cause roughly 300 
million premature deaths by 2050, with a loss of up to $100 trillion to the global economy.16 
There will be a time soon where antibiotic treatment will cease to defend humanity against these 
microbes. Therefore, a novel non-antibiotic treatment towards harmful bacteria must be found. 
 
I.4. Drug Discovery And The Search For New Antimicrobial Agents 
            As stated previously, there is a growing problem for discovering new chemical 
compounds that are not only better antimicrobials, but do not originate from conventional 
antibiotic families. Simple small molecules such as organic compounds from different classes 
received a large amount of screening and preliminary assessment, but all failed due to intrinsic 
toxicity to mammals. Difficulties in modification of these organic compounds to tailor desired 
stability and solubility, result in prohibitive costs. The studied classes of organic compounds 
were heterocycles, aromatics, porphyrins/phthalocyanines,17 carbohydrates,18 and small peptides. 
Joseph Lister introduced phenol as a form of sterilization in surgery,19 while some halogenated 
compounds - chloramines – have been shown to express antibacterial properties.20-22  
            Among classic antimicrobial inorganic compounds a large variety of silver (I), 23 
mercury(I), 24 copper(II), 25 and zinc(II) 26 complexes were studied. Other than some silver(I) 
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derivatives, no elements were successfully applied as effective antimicrobial treatments. For 
example, silver(I) has been used in wound treatment fabric, as a colloidal solution for topical 
applications. Other silver-based compounds and compositions have various infection reducing 
properties. Silver alloys, silver oxides, and silver sulfadiazine are coated on surfaces of various 
implants, such as urinary and central venous catheters.27-29 Other disinfection applications of 
silver(I) are silver-silica nanorattles used in implant cavity disinfection,30 and silver ions 
dispersed on a proprietary polymer for disinfection of ventilator endotracheal tubes.31  
            Silver antimicrobial applications have been on the rise due to the increasing issue of 
MDR bacteria. A main contributor towards use of silver antimicrobials is their lower toxicity 
towards human cells and tissues.32 Silver has shown to exhibit strong bacteriostatic and 
bactericidal effects, which are correlated by its interactions with bacterial DNA and deactivation 
of bacterial respiration enzymes.33 Studies have also indicated that silver ion interactions can 
contribute to the generation of reactive oxygen species (ROS).34, 35 In the case of silver 
nanoparticles (AgNPs), there is evidence of direct interaction with the cell surface, allowing 
penetration through the cell membrane causing leakage and eventual cell death.36, 37 Interference 
with membrane permeability and inhibition of transcription and translations have also been 
reported.38, 39 Even though silver antimicrobials in clinical treatment have shown promise, there 
are several hurdles with the application. The largest hurdle for silver(I) inorganic compounds 
corresponds to the reduction of the metal cation to elemental Ag(0), when exposed to light and 
heat.40, 41 Overall, organometallic compounds have not been thoroughly investigated as 
antimicrobial agents, but they represent a suitable combination of chemical stability, 
lipophilicity, and novelty. These characteristics pose a threat towards antibiotic-resistant 
microbes as these bacteria have yet to develop resistance toward organometallics. 
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II. LITERATURE REVIEW 
 
II.1. Introduction Of Bioinorganic Chemistry 
            Bioinorganic chemistry is a young field of the science and is concerned with the roles 
that inorganic elements pose in biological systems and processes.42 Metal ions can have roles 
incorporated in structures, catalytic reactions, transportation (heme group with O2), or all the 
above. Representation of elements found in the human body can be seen in Table 1. Bioinorganic 
chemistry officially began with the revolutionary work done by Paul Ehrlich, Alfred Bertheim, 
and Sahachiro Hata when they developed the first successful antimicrobial arsenic-based drug, 
Salvarsan. This drug was one out of more than 300 arsenic compounds which was toxic towards 
the microbe that caused syphilis, but not towards the human host. A dose response curve can be 
attributed to determination of optimal concentration of doses with certain elements (Figure 1). 
Studying the change in growth of cells with respect to concentration of dosage is crucial to 
determine which concentrations are safe, optimal, and hazardous. In the case of antimicrobial 
activity, it is important to find the ideal concentration of inhibition towards microbe growth 
(Figure 2). These tools are very useful in progressing development of antimicrobial, 
antibacterial, and antifungal treatments.  
 
II.2. Antimony: Chemistry And Applications 
            Antimony is a metalloid chemical element with the symbol Sb and an atomic number of 
51. Antimony has been known since ancient times. The element “antimony” was named around 
~50 AD, where the Roman scholar Pliny gave the name stibium. The original discoverer of 
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antimony is not known, but many people attribute antimony with Nicolas Lemery, a French 
chemist that performed one of the earliest studies on the element. Other writings attributed to the 
 
Table 1. Elements and weight percentages found in the human body.a 
 
aData from Ref. 42. 
 
 
Figure 1. An example of a dose-response curve. Copied from Ref 42. 
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Figure 2. Representation of the concentration dependence of toxic and beneficial effects of metal 
ions on cell growth. Reprinted from Ref 42. 
 
 
Arabic father of chemistry Jabir ibn Hayyan used the name antimonium.43 Antimony has the 
electronic structure [Kr] 4d10 5s2 5p3 and has readily accessible oxidation states of -3, 0, +3, and 
+5. The trivalent and pentavalent oxidation states of antimony are the most important as they are 
found more commonly in nature. There are two stable isotopes of antimony, 121Sb with a natural 
abundance of 57.36% and 123Sb with a natural abundance of 42.64%. There are also, 35 
radioisotopes, with the longest-living isotope being 125Sb with a half-life of 2.75 years.44 As 
antimony is chemically reactive, it forms numerous chemical compounds. Values of various 
bond energies of electron withdrawing elements with antimony can be found in Table 2. 
II.1.1. Applications of antimony. Antimony can be found naturally as sulphide and 
oxide ores, which are present in two forms, stibnite (Sb2S3) and valentinite (Sb2O3).
43, 45 These 
ores can be found in large quantities in China, South Africa, Mexico, Bolivia, and Chile. Less 
common sulfide ores include ullmanite (NiSbS), livingstonite (HgSb4S8), tetrahedrite (Cu3SbS3), 
wolfsbergite (CuSbS2), and jamesonite (FePb4Sb6S14). One of the traditional treatment methods 
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occurs by roasting stibnite or valentinite ore with charcoal or coke to promote a volatile oxide 
fume (Sb4O6), which can then be refined into pure antimony.
46 During ancient times, stibnite was 
commonly used for cosmetic purposes in Egypt. The distribution of domestic antimony 
consumption is estimated as follows: nonmetal products (including ceramics, glass, and rubber 
products), 22%; flame retardants, 40%; and metal products, such as antimonial lead and 
ammunition, 39%.47 
            One of the important uses of antimony metal is as a hardener in lead alloys for storage 
batteries. Antimony metal has other applications in solders and other metal alloys. Some other 
uses for antimony alloys include “type metal”, which is used in printing presses, bullets, and 
cable sheathing.43 Stibine (SbH3), a gaseous compound used in semiconductor technology, where 
the purified gas serves as a n-type dopant for silicon. One of the most commercially relevant 
antimony compounds used today is the trivalent antimony trioxide Sb2O3. The compound is 
processed from the metalloid and is used in polyethylene terephthalate and flame-retardant 
production, and as an additive in paints, pigments, and ceramics.43 Some flame-retardant 
applications are used in aircraft and automobile seat covers and children’s clothing and toys.43, 49  
           II.1.2. Medicinal applications of antimony. Organoantimony compounds have shown 
significant antimicrobial,50 antitumor,51- 53 and antifungal activity.54, 55 Organoantimony 
compounds also show antitumor activity in some diphenylorganoantimony(V) thiophosphates 
such as Ph2Sb{S2- PR2} (Ph = C6H5, R = Ph, i-OC3H7) 
56, 57 and methylantimony(III) complexes 
like (CH3)SbL (L = derivatives of meta-substituted salicylic acid.
58 Due to similarity of the 
mechanism, cytostatic activity 59 is attributed to these complexes, which is correlative to 
cisplatin. Furthermore, the biological toxicity of organoantimony is much less than that of Pt and 
Pd in the case of anticancer 
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Table 2. Bond energies between Sb and halogens, chalcogens and N - typical ligands in 
organoantimony compounds taken from reference.a 
______________________________________________________________________________ 
                                            Sb – E                                           E, kcal/mol 
______________________________________________________________________________ 
                                             Sb-F                                             105 ± 23 
                                             Sb-Cl                                            86 ± 12 
                                             Sb-Br                                            75 ± 14 
                                             Sb-O                                             103.7 ± 10 
                                 Sb-S                                              90.5 
                                 Sb-Te                                            66.3 ± 0.9 
                                 Sb-N                                             110 ± 20 
aData from Ref. 48. 
 
substances.60 In addition, antimony compounds have been used in treatment against the parasitic 
disease leishmaniasis for about a century. 
            Leishmaniases is caused by the protozoan parasite under the genus Leishmania which 
then multiplies in certain vertebrates.61 The parasite is transmitted to humans through the bite of 
sandflies that are infected. Multiple forms of the disease exist, the two most known are cutaneous 
leishmaniasis (CL) the most common form and visceral leishmaniasis (VL) the most severe. The 
earliest treatment reported of CL used a trivalent antimonial, tartar emetic, in 1913.62 Over a 
decade after the report, tartar emetic was criticized as an antimonial due to side effects such as 
heavy coughing, chest pain, and severe depression.61 In addition, the compound was found to be 
very unstable in a tropical climate and highly toxic.63 The disadvantages posed by trivalent 
antimonials lead to the discovery of treatment with pentavalent antimonials. These included urea 
stibamine. 64,65 antimony gluconate,66 and sodium stibogluconate.67 Currently, the most 
commonly used organoantimony compounds against leishmaniasis are the pentavalent sodium 
antimony gluconate (Pentostam) and meglumine antimoniate (Glucantime).  
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            The most accepted, proposed mechanism of pentavalent antimonial is their behavior as 
prodrugs. 68 The pentavalent prodrug undergoes in vivo biological reduction into a much more 
active/toxic trivalent antimony. This Sb5+ to Sb3+ reduction requires thiol compounds of both 
mammalian and parasitic origin. 69-71 Mammalian thiols include glutathione (GSH), cysteine 
(Cys), and cysteinyl-glycine (Cys-Gly). Glutathione is the main thiol in the cytosol, while 
cysteine and cysteinyl-glycine are the predominant thiols within lysosomes of mammalian cells. 
72, 73 The parasitic thiol compound required is trypanothione (T(SH)2), this complex consists of 
glutathione and spermidine. Intake of pentavalent antimony into parasitic cells has been 
suggested to occur by monoadduct formation between Sb5+ and nucleotides.74 This can be 
attributed to nucleotides containing vicinal cis-hydroxyl groups (i.e. adenosine, cytidine, 
guanosine, uridine, and AMP), where binding occurs at the deprotonated hydroxyl group of the 
ribose moiety.75 The complexation leads to nucleotides acting as carriers for Sb5+ into parasites 
via lipophospholycan (LPG) transporter.74 Figure 3 represents the intake of metal compounds 
and ions into the cell either through passive diffusion or an ion specific channel. Once inside the 
parasitic cell, the application of a prodrug can proceed. The reduction can occur enzymatically 
(through ACR2 or TDR1 reductase) or non-enzymatically. Once the reduction has occurred 
complexation between glutathione or trypanothione.  
            The first site of interference is with the trypanothione/TR system. This system maintains 
trypanothione in the reduced state to balance the oxidoreductive balance in the Leishmania 
parasite. This balance protects the cell from oxidative stress damage, toxic heavy metals, and 
delivers reducing power for DNA synthesis.76, 77 Trivalent antimonials interfere with 
trypanothione metabolism by inhibiting trypanothione reductase (TR) and inducing rapid efflux 
of intracellular trypanothione and glutathione into unaffected Leishmania cells which lead to 
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apoptosis. The second site of attack by trivalent antimony is with the CCHC zinc finger domain. 
Zinc fingers can be characterized by the coordination of zinc with several amino acid residues, 
typically cysteine  
and histidine. This domain has purpose in a variety of diverse functions such as DNA recognition 
and replication and structure and repair,78 RNA packing, protein folding and assembly, lipid 
binding, transcriptional activation, cell differentiation, cell growth, and regulation of apoptosis.79 
Once trivalent antimony is bound to the zinc finger domain, promotion of efflux of Zn2+ occurs, 
leading to apoptosis.80 Figure 4 illustrates the prodrug model. 
 
Figure 3. Schematic representation of how chemical compounds enter the cell, taken from 
literature. Reprinted from Ref 74. 
 
II.3. Coordination Compounds: An Introduction 
            Coordination compounds, often referred to as “Werner-type” (Figure 5), contain a central 
atom and ligands. The central atom is usually a metal ion, such as Cu, Ni, Fe, or metalloids, such 
as Sb, As, and Ge. While the ligands can be various types of inorganic molecules such as H2O, 
NH3, SO2, N2, inorganic anions (Cl
-, OH-, F-, Br-, NCS-, N3
-, CN-), or small organic molecules 
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(pyridine, 1,2-ethylendiamine, amino acids, etc.). In general the organic ligands can vary heavily, 
but the most interesting are mixed-donor ligands, allowing the opportunity to construct new 
structure with higher complexity.42 Among the latter ligands, oximes have a special role of 
being: a) multidentate ligands, and b) possess biological activity. Types of oximes are shown in 
Figure 6. 
  




















































aldoximes ketoximes cyanoximes amino & imido oximes  
Figure 6. Currently known types of cyanoximes and their precursors. 
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II.4. Cyanoximes: Ligands For Coordination Compounds   
          Oximes are ampolydentate organic ligands, which have known biological activity. As of 
events in the Spring of 2020, there are now newly developed antiviral oxime-containing 
compounds that showed activity against HIV, SARS-CoV-2, and MERS-CoV-2, which are now 
in different stages of clinical trials.82 The structures of these oxime compounds are shown in 
Figure 7. This ampolydentate behavior can be seen with the ACO- cyanoxime anion with various 
metals (Figure 8). All cyanoximes represent not only ampolydentate ligands, but also 
demonstrate rich stereochemistry. Therefore, we observed with years of study of these compouds 
four distinctive geometries shown in Figure 9. Each isomer was confirmed by X-ray analysis. No 
interconversion of these isomers was observed.  
            Cyanoximes represent a new, unique class of biologically active compounds capable of 
binding to various metals.83 The general structure for cyanoximes is HO-N=C(CN)-R, where R 
represents the varying electron withdrawing group, typically O, N, or S. The presence of the 
electron-hungry nitrile (CN) group significantly increases the Lewis acidity making them better 
ligands to bind metals ions in solution than regular monoximes.60 The nitrile group allows 
deprotonation of the cyanoxime in alkaline medium very facile in aqueous and polar organic 
solvents.84-86 The color originates from a ground state to a low-lying excited state n π* in the 
nitroso-chromophore in the visible region of the spectrum.87-89 Figure 10 represents the 
deprotonation behavior. In addition, cyanoximes have a resonance system delocalization of 
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Figure 9. Geometrical isomers of cyanoximes. 
 
            Cyanoximes were found to have shown significant biological activity such as 
antimicrobial, 93, 94 growth-regulating,95 and detoxifying agricultural pesticide properties 96 
making them useful in a variety of applications. Earlier data demonstrated no intrinsic in vitro 
cytotoxicity of free cyanoximes.97-99 Also, cyanoximes have shown antimicrobial activity with 
some of their Ag(I) salts and the sulfur-containing thioamide-cyanoxime, HO-N=C(CN)- 
C(S)NH2, and its K
+, Na+, Cu2+, Ni2+ salts.100, 101 There are 44 known cyanoximes today (Figure 
12), where eight of those ligands were selected for currents studies from the library as discussed 
in Part II (Figure 13). The ligands were chosen based off known biological activity and those 
with some water solubility. 
            The source of antimony for the organoanimtony(V) cyanoximates is from Sb(Ph)4Br. The 
[Sb(Ph)4] moiety was selected due to its commercial availability as a colorless and crystalline solid 
compound. We realized that the tetraphenyl antimony possesses considerable lypophilicity, but we 
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needed to prove the concept that the combination of known biological cyanoxime ligands and the 
[Sb(Ph)4] moiety will produce useful compounds. Regardless, it was important to develop a viable 
synthetic route of organoantimony(V) cyanoximates in general. Therefore, to summarize, this 
research was conducted for the purpose to try to combine the biological properties of both 
organoantimony and cyanoximes ligands, in the hope development of new antimicrobial 
compounds of non-antibiotic nature. 
 
 
Figure 10. Deprotonation of cyanoximes with metal carbonates, hydroxides, and oxides in 


































X = O;   R = NH2,   N(CH3)2,  NH-NH2,  O-Et,  Ph,  t-Bu
X = S;   R = NH2,   N(CH3)2  
Figure 11. Charge delocalization in yellow cyanoxime anion involving several resonance forms. 
Taken from Ref. 91. 




Figure 12. List of known cyanoximes ligands. Asterisks indicate compounds for which crystal 












III. RESEARCH GOALS 
 
            My work proposes novel research in Dr. N. Gerasimchuk’s lab. It was focused on the 
synthesis of eight new organoantimony (V) cyanoximates with the purpose of performing 
antimicrobial studies against Methicillin-resistant Staphylococcus aureus strain NRS70, 
Escherichia coli strain S17, and Pseudomonas aeruginosa strain PAO1. Therefore, we wanted to 
investigate the preparative and coordination chemistry of our tetraphenyl organoantimony (V) with 
a group of selected cyanoximes (Figure 13). Literature review described the importance of a new 
nonantibiotic treatment against resistant, harmful strains. Therefore, incorporating the medicinal 
applications of antimonials and antimicrobial activity of silver(I) cyanoximes will further develop 
this field of research. Hence, are the following goals for this research project:  
1. To synthesize a series of eight novel compounds and conduct their characterization 
using available spectroscopic methods and X-ray analysis.  
2. Sumbit pure and fully characterized compounds for in vitro antimicrobial and 
antifungal studies at a collaborative university – Oklahoma State University, Stillwater 













IV.1. Experimental And Characterization Methods 
             IV.1.1. Reagents and general considerations. Reagent grade morpholine (C4H9NO), 
toluene (C7H8), ethyl cyanoacetate (C5H7NO2), chloroform (CH3Cl), and our source of 
organoantimony, Sb(C6H5)4Br at ~95% purity, was purchased from Sigma Aldrich. All other 
chemicals and organic solvents – isopropyl alcohol (i-PrOH), acetonitrile (CH3CN), diethyl 
ether, sodium nitrite (NaNO2), concentrated sulfuric acid (H2SO4), and concentrated hydrochloric 
acid (HCl) from Fisher Scientific and sodium metal from Fluka – were of sufficient quality, and 
used without additional purification. 
            Cyanoximes and their silver(I) derivatives selected for current studies were either taken 
from a bank of ligands in Dr. Gerasimchuk’s research laboratory or obtained using published 
procedures from starting substituted acetonitriles. Therefore, compounds such as H(2PCO), 
Ag(3PCO), Ag(4PCO), Ag(ACO) and  Ag(ECO), were used for syntheses of organoantimony(V) 
cyanoximates from previous investigations1, while H(MCO) was prepared and purified in this 
research. The thioamides-based cyanoximes H(TCO), H(TDCO) as well as all Tl(I)-
cyanoximates were prepared by Dr. Gerasimchuk in order to avoid graduate students’ exposure 
to stench or toxic chemical compounds. Melting points were determined with the help of pre-
calibrated apparatus with urea and naphthalene standards Digi-Melt (MPA106 SRS) in open 
melting point capillaries, and reported without correction. Elemental analysis on C, H, N (and S 
with thioamide-based cyanoximes) content was conducted at the Atlantic Microlab (Norcross, 
GA).  
                                                 
1 Mark Whited, Daniela Marcano, Jeff Morton 
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             IV.1.2. Vibrational spectroscopy. The IR-spectra of all compounds reported herein 
were samples of studied compounds with the help of Bruker ATR FT spectrophotometer. The 
resolution was set to be 4 cm-1 with 64 scans in the range of 400 – 4000 cm-1. An atmospheric 
compensation and baseline correction were applied for data treatment.  
             IV.1.3. UV-visible spectra. The electronic spectra of selected organoantimony(V) 
cyanoximate compounds were recorded in solutions using the HP 8354 diode array UV-visible 
spectrophotometer operating in the range of 200 – 1100 nm typically at room temperature. In 
cases where variable temperature spectra were needed, a high precision Peltier Quantum 
Northwest thermocontroller was used with 1 cm quartz cuvettes. Data of spectroscopic studies 
are presented in appropriate places in the thesis.  
             IV.I.4. NMR spectra. The spectra were obtained on a Varian INova-400 MHz 
spectrometer at room temperature in DMSO-d6 and CDCl2 solutions for 
1H and 13C, respectively.  
             IV.1.5. X-ray crystallography. Suitable single crystals of organoantimony(V) 
cyanoximates were grown at +4oC exclusively using the vapor diffusion method: acetonitrile 
solutions of compounds were placed into the inner tube and vapors of anhydrous ether were used 
as crystallizing agent from the outer tube with a screw cap. Normally within 2-3 weeks after 
setting up, transparent, well-shaped crystals appeared on the walls in the inner tube suitable for 
crystallographic studies. All crystals selected for studies were placed on plastic MiTeGen holders 
attached to the copper-pin on the goniometer head of the Bruker APEX-2 diffractometer, 
equipped with a SMART CCD area detector. The intensity data were collected at low 
temperature. Data collection was done in  scan mode using the Mo tube (K radiation;  = 
0.71073 Å) with a highly oriented graphite monochromator. Intensities were integrated from 4 
series of 364 exposures, each covering 0.5o steps in  at 20 – 60 seconds of exposition time 
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depending on the crystal diffracting power, with the total data set being a sphere. The space 
group determination was done with the aid of the XPREP software. The absorption correction 
was performed by a crystal face indexing procedure with a help of a video microscope followed 
by numerical input into the SADABS program. Both cited programs are included in the Bruker 
AXS software package. All structures were solved by direct methods and refined by least squares 
on weighted F2 values for all reflections with I >3Ϭ(I) using the SHELXTL program. In several 
structures it was possible to identify all H-atoms on the electron density map due to the high 
quality of crystals. However, in some structures H-atoms were placed in calculated positions in 
accordance with the hybridization state of a hosting carbon atom and were refined isotropically. 
No apparent problems or complications were encountered during the structures’ solutions and 
refinement as evident from very positive PLATON checkCIF reports. Values of selected bond 
lengths and valence angles are presented in respective Tables following the discussion of crystal 
structures. A representative drawing of the crystal structures and packing diagrams was done 
using the ORTEP 3v2 and Mercury software packages. All determined crystal structures have 
been deposited at CCDC (England), with PLATON checkCIF reports. 
             IV.1.6. Thermal Stability Studies. Thermal stability of the obtained metal complexes 
was assessed using Q-600 TG/DSC analyzer (TA Instruments) under N2 flow of 100 mL/min at 
10o/min heat rate. Appendix A-1 briefly explains the use of the instrument. Heating of samples 
was carried out to 800oC at which the samples’ complete decomposition was attained. Some of 
the results of thermal analyses studies are presented in during discussion section with the rest of 




IV.2. Synthesis Of HMCO: Synthesis Of 3-Morpholin-4-yl-3-oxoproprionitrile, The HMCO 
Cyanoxime Precursor, Pre-MCO 
           Preparation of this ligand represents a two-step procedure (Figure 14), where we used two 
methods for the amide precursor preparation. The first method for synthesis of pre-MCO used 
dichloromethane as the solvent, and a mixture of morpholine, ethyl cyanoacetate, and 
dichloromethane 1:1:1 (gram based) was prepared in a 25 mL amber glass bottle. Nitrogen gas 
was then bubbled into the solution under stirring for 10 minutes. The bottle was then capped, 
wrapped in parafilm, and placed in the freezer at a temperature of 0°C until crystallization of the 
target amide. Crystallization of the desired pre-MCO compound occurred between one to two 
weeks. The crystals were then filtered and washed with 35 mL of toluene followed by 35 mL of 
hexane and dried in a desiccator charged with concentrated sulfuric acid for a week. The yield 
was 82% (1.434 g): calculations of which were based on ethyl cyanoacetate as the limiting 
reagent.  
A second method for the synthesis of pre-MCO used chloroform as the solvent, as a similar 
procedure previously mentioned. A mixture of morpholine, ethyl cyanoacetate, and chloroform 
1:1:1 (gram based) was prepared in a 25 mL amber glass bottle. Synthesis follows as previously 
mentioned. Crystallization of the desired pre-MCO amide compound occurred between one to 
two weeks. The crystals were filtered and then washed with 35 mL of toluene and then 35 mL of 
hexane and dried in a desiccator charged with concentrated sulfuric acid for a week. The yield 
was 77% (1.224 g): Similarly, calculations of yield were based on ethyl cyanoacetate as the 
limiting reagent. The two methods of preparation of the pre-MCO amide compound can be found 
in Figure 14A. 
 
27 
IV.3. Synthesis Of H(MCO): From Its Precursor (pre-MCO) 
           Nitrosation of the pre-MCO was performed at room temperature by bubbling methylnitrite 
in basic conditions explained in published procedures (Figure 14B).[101] Yield of the final product 
was 65% (1.11 g) from 1.434g pre-MCO, mp.: 170-173 °C, and Rf = 0.36 in EtOAc/hexane = 3:1 
mobile phase. The 13C{1H} NMR spectra of H(MCO) were recorded in DMSO-d6. Where the 
1H 
NMR, in ppm, had chemical shifts of 14.27 (OH), ring protons - 3.32 (CH2 next to O), and 2.54 
(CH2 next to N). The 
13C NMR chemical shifts were analogous with previous literature reported 
in.101 Bands in IR spectrum of H(MCO), in cm-1, were: 3422, 2969, 2831, 2239, 1621, and 1006. 
 
 
Figure 14. A, Synthesis of the H(MCO) from its precursor obtained in two different ways. B, 
nistrosation of pre-MCO amide compound into protonated cyanoxime ligand. 
 
 
IV.4. Synthesis Of Ag(I)L Salts From HL Acids 
           There were some AgL (L = cyanoxime anion ligand) available from previous 
investigations in our laboratory, which were needed for organoanitmony(V) cyanoximates. 




retrieved from the library of compounds in our lab.  Preparation of Ag(I) complexes began with 
deprotonation with K2CO3, followed by coordination with Ag through addition of AgNO3 
(Figure 15). The typical synthesis of silver(I) derivatives is shown as an example for only one 
compound. Thus, white H(2PCO) in the amount of 0.4605 g (2.46 mmol) was dissolved in a 
mixture of 10 mL of EtOH, then diluted with 10 mL of water, heated to 55°C, and then added 
dropwise to a solution of 0.169 g (1.22 mmol) of K2CO3 in 10 mL of H2O. The color of the 
solution immediately turned yellow signifying the presence of the nitroso anion. The reaction 
mixture was placed for 2 min into an ultrasound bath to accelerate the evolution of CO2. A 
solution of 0.4183 g (2.46 mmol) of AgNO3 in 10 mL of water was added dropwise under 
intensive stirring to a solution of K(2PCO) above. Mixing resulted in a very fine yellow 
precipitate, which after an additional 20 min of stirring was filtered, washed with three portions 
of 10 mL of water, and then dried in a vacuum desiccator charged with H2SO4 (conc.) for 3 days. 
Analytical data for desired Ag(MCO) and Ag(2PCO) were reported in a MS thesis from a 
previous lab member 101 and published work, 102 respectively. 
 
 
Figure 15. General synthesis of silver(I) salts of cyanoxime ligands from their protonated 





IV.5. Synthesis of Sb(Ph)4L, The Metathesis Reaction 
           Tetraphenylantimony(V) cyanoximates were obtained using a metathesis reaction of 
previously prepared Ag(I) salts and tetraphenylantimony(V) bromide described in literature  
(Figure 16).60 This method was found to be the most convenient way to synthesize 
organoantimony(V),60 organotellurium (IV),103 and organotin(IV) 97 compounds. The initial 
compound SbPh4Br is a commericially available source of pentavalent antimony. One typical 
synthesis of organoantimony(V) cyanoximates is depicted below. The preparation of 
Sb(Ph)4(ACO) was conducted by adding 0.201g (0.394 mmol) of Sb(Ph)4Br to 10 mL of dry 
acetonitrile (CH3CN) in a 25-mL Erlenmeyer flask then swirled until completely dissolved. Then 
under a red-light emitting lamp, 0.0865g (0.414 mmol) of finely grinded, solid Ag(ACO) was 
added in small portions to the flask and sonicated for five minutes for efficient mixing of this 
heterogeneous reaction. Following sonication, filtration of the white AgBr precipitate was done 
using two methods in the dark: a) by vacuum filtration and b) centrifugation with nylon 0.45 
micron membrane, Eppendorf tubes (Figure 17).  
           In the vacuum filtration method, the first colorless filtrate was transferred in Erlenmeyer 
flask for storage and crystal growth. The product was washed with 5 mL portions of CH3CN, 
until the filtrate did not glow under UV light when spotted on a TLC plate. This technique was a 
way of controlling completeness of washing our desired product while filtering out the AgBr 
byproduct. Once all product was filtrated out and washed, each portion was added to the storage 
flask, and put into a desiccator with paraffin until acetonitrile was evaporated. This is possible, as 
paraffin wax absorbs alkanes like our solvent CH3CN. As for filtration through centrifugation, 
the cloudy solution of our desired organoanimtony(V) cyanoximate and AgBr was transferred 
into filtered nylon Eppendorf tubes and centrifuged in a Thermo Scientific Sorvall Legends 
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Micro 17 at 10,000 rpm for three minutes. Following centrifugation, AgBr can be visibly seen at 
the bottom of the Eppendorf tubes in a clear solution. The transfer of the mentioned clear 
solution was placed inside a beaker and put into a desiccator with paraffin for crystallization. The 
progression of centrifuge filtration for Sb(Ph)4(MCO) is shown in Figure 18. Synthesis 
information regarding compounds’ color, yields, and data of elemental composition 
determination presented in Table 3. 
 
Figure 16. General synthesis of organoantimony(V) cyanoximates using the metathesis reaction 




Figure 17. Instrumentation and accessories used for isolation of organoantimony(V) cyanoximates 






Figure 18. Progression of filtration using centrifugation a homogenous mixture of Sb(Ph)4(MCO) 




IV.6. Synthesis Of Thioamide Sb(Ph)4L′, From TlL′ Salts 
           Two thioamides TCO- and TDCO- do not form Ag(I) derivatives because of the fast 
decomposition reaction resulting in a black Ag2S precipitate formation. Therefore, a methathesis 
reaction using TlL′ was incorporated for the thioamide containing ligands. Contrary to Ag(I) 
complexes of some cyanoximes,104 Tl(I) compounds are light-stable and readily formed with 
thiols and thioamides.105  
           For preparation of Sb(Ph)4(TCO), 0.155 g (0.304 mmol) of white Sb(Ph)4Br was 
dissolved in 8 mL of CH3CN. Then 0.101 g (0.304 mmol) of a solid, yellow powder Tl(TCO) 
(Figure 19) was suspended in 4 mL of CH3CN and mixed with first solution. Sonication was 
used to insure proper mixing of the solution and suspension at room temperature. After 10 
minutes of sonication, filtration via centrifugation went exactly as mentioned previously, 
receiving a clear yellow solution and a colorless TlBr precipitate. The filtered solution was then 
placed in a beaker and stored in a charged desiccator, with paraffin wax (for CH3CN absorption), 
for crystallization. The crystalized product is shown in Figure 20. Thus, preparation of Sb(Ph)4L′  
(L′ = TCO-, TDCO-) was accomplished using the metathesis reaction shown in Figure 21. This is 
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accomplished easily as Tl(I) halides (similar to Ag(I) halides) readily precipitate in aqueous and 
nonaqueous solutions. Synthesis of both thioamide containing cyanoximates follows. 
 
 
Figure 19. Microscopic image of the Tl(TCO) salt.  
 
 
Figure 20. Microscopic image of desired crystalline organoantimony(V) cyanoximate, 
Sb(Ph)4(TCO). 
 
           As for the synthesis of Sb(Ph)4(TDCO), 0.206 g ( 0.404 mmol) of white Sb(Ph)4Br was 
dissolved in 8 mL of CH3CN. Then, 0.143 g (0.404 mmol) of finely grinded, orange Tl(TDCO) 
was readily dissolved in 4 mL of CH3CN. The two solutions were sonicated for 10 minutes, 
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filtered via centrifuge, and left for crystallization in the same procedure as before generating a 




Figure 21. General synthesis of organoantimony(V) cyanoximates using the metathesis reaction 
with thallium(I) salts. L’ represents the thioamide containing ligands. 
 
 
Figure 22. Microscopic image of desired crystalline organoantimony(V) cyanoximate, 
Sb(Ph)4(TDCO). 
   
IV.7. Antimicrobial Studies: Kirby-Bauer Single Disk Test 
           The Sb(Ph)4(MCO), Sb(Ph)4(ECO), Sb(Ph)4(TCO), Sb(Ph)4(TDCO), and Sb(Ph)4(ACO) 
compounds were chosen for initial inhibition zone measurements. One of the precursors of the 
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metathesis reaction, Sb(Ph)4Br, was used as a control. The procedure of applying compounds to 
disks follows. Using 100% cotton paper, disks were cut with a hole-punch. 25 μl aliquot samples 
of three different concentrations (stock, x2, and x4 dilution factor) of compounds dissolved in 
acetonitrile were transferred onto paper disks and left to dry on a Teflon surface for 20 minutes.  
Following disk preparation, inhibition zone measurements were conducted at another institute, 
Oklahoma State University. Methicillin-resistant Staphylococcus aureus strain NRS70, 
Escherichia coli strain S17, and Pseudomonas aeruginosa strain PAO1 were used. Precultures 
were prepared by inoculating 3 mL of LB medium with a strain culture. The mixture was then 
incubated at 37 °C at 200 rpm for 12 hours via a Thermo scientific MaxQ 4000. Before plate 
inoculation, the cultures were collected and diluted to obtain an optical density of 600 (OD600) 
at 0.1. Next, 100 μl of normalized culture was spread onto LB agar plates (15 mL of LB in each 
plate). 10 μl of phosphate buffered saline (PBS) was then applied on the plate followed by 
placement of compound-adsorbed disks. Fully prepared plates were then incubated at 37°C for 
24 hours, after incubation clearance zones were measured. 
 
IV.8. Antimicrobial Broth Dilution Minimal Inhibition Concentration (MIC) Assays 
           The same strains selected in the previous antimicrobial assay were used for broth dilution 
MIC studies. The strains were tested against 4 compounds: Sb(Ph)4(MCO), H(MCO), H(ECO), 
and Na[H(ACO)2]. MIC assays were determined using a similar published procedure.
107 
Precultures of the selected strains were grown for 12 hours in Mueller Hinton broth (MHB) at 
37°C 200 rpm. The four compounds previously mentioned were put into 10 different 
concentrations, starting at 0 to 500 μg/mL in increments of 50. The compounds were dissolved in 
DMSO ranging from 0 to 10% in increments of 1% for the gradient. The cultures were then 
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normalized to an OD of 0.1 using a spectrophotometer, then 120 μL of OD 0.1 was diluted 50X. 
Next, 100 μL of the dilution inoculate solution was placed into a 100 μL well plate with the 
appropriate antimicrobial compound solution. The wells were then incubated again at 37°C and 
200 rpm until two time intervals occurred, 6 and 24 hours. Once reaching both time slots, the 
OD600 was then measured. 
 
IV.9. Antifungal Studies: Kirby-Bauer Single Disk Test And MIC Assays 
 The protonated ligands Na[H(ACO)2], H(MCO), H(ECO), and the organoantimony 
cyanoximate Sb(Ph)4(MCO) were chosen for inhibition zone and MIC determination assays. 
Fungi used in these experiments were Cryptococcus neoformans and Candida albicans. For all 
experiments, both MIC and disk diffusion, the fungi were grown in Yeast Extract-Peptone-
Dextrose (YDP) broth at 30°C for 16-18 hours. Then fungi were washed three times with PBS 
before adjusting to required concentration for the specific assay. In the MIC assays, the media 
was RPMI-MOPS, at a pH of 7.4, and with a fungal concentration of 0.5x103 cells/mL. In 
addition, fungi were incubated for 48 hours at 35°C, then visually inspected the plate and took 
optical density readings on a platereader to confirm visual inspection. For the disk diffusion 
assays, the media was PBS and the fungal concentration used was 1x106 cells/ mL. The disk was 
applied to the center of a YPD plate previously spread with the specific fungal culture. The plate 
and disk were then incubated at 30°C for 48 hours, then zone of inhibition around the disk was 





Table 3. Color, yield, and elemental analysis of synthesized organoantimony(V) cyanoximates and their precursors. 
Color Yield (%) C, % Calc. (Found) H, % Calc. (Found) N, % Calc. (Found) S, % Calc. (Found)
pre-MCO white 65 - - - -
HMCO off-white 82 - - - -
Ag(MCO) yellow 28.99 (28.19) 2.78 (2.81) 14.49 (14.06) -
Sb(Ph)4(MCO) colorless 90 60.81 (59.48) 4.61 (4.52) 8.86 (6.47) -
Sb(Ph)4(2PCO)∙H2O colorless 45 64.61 (64.34) 4.20 (4.07) 7.29 (7.19) -
Sb(Ph)4(3PCO) colorless 84 64.61 (62.17) 4.20 (3.99) 7.29 (6.51) -
Sb(Ph)4(4PCO) colorless 46 64.61 (63.93) 4.20 (3.93) 7.29 (7.31) -
Sb(Ph)4(ACO) colorless 79 59.81 (58.39) 4.09 (4.16) 7.75 (7.29) -
Sb(Ph)4(ECO) colorless 91 60.86 (60.59) 4.58 (4.44) 4.89 (4.94) -
Sb(Ph)4(TDCO) golden yellow 51 59.40 (58.84) 4.47 (4.37) 7.17 (6.20) 5.47 (4.64)
Tl(TCO) yellow 10.84 (10.77) 0.61 (0.54) 12.64 (12.71) 9.64 (9.52)
Sb(Ph)4(TCO) yellow 51 58.08 (57.93 3.97 (3.84) 7.53 (7.42) 5.74 (5.59)
Elemental analysis, element % 
Compound
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V. RESULTS AND DISCUSSION 
 
V.1. X-Ray Single Crystal Analysis 
           The crystals of all complexes were successfully grown using two different methods: 1) by 
slow crystallization through evaporation of a CH3CN solvent, or 2) through the vapor diffusion 
when ether helped with crystallization. Most compounds were simple and easy to crystallize with 
method 1, while some hard to crystalize compounds were accomplished with 2. The Sb(Ph)4L 
complexes of H(2PCO), H(3PCO), H(4PCO), H(ECO), H(MCO), H(TCO), and Tl(TDCO) were 
crystallized and analyzed. Most crystal structures were initially determined by Dr. Gerasimchuk, 
while later determination of the full crystal report was accomplished by me for learning 
purposes. The structures were solved using direct methods incorporated into the SHELXS – 2013 
and refined using the Bruker SHELXTL Software Packages.108 In the case of crystal twins, 
application of the detwinning procedure followed by absorption correction was accomplished 
with the help of TWINABS.109 Some of the drawings of molecular structures were done with 
ORTEP 3v2,110 while the other molecular structures and packing diagrams for structures were 
performed using the Mercury Program.111 Below we present brief descriptions of 
crystallographic results in this study. All the presented structures were assigned Cambridge 
Crystallographic Data Centre (CCDC) numbers, the checkCIF reports for each structure can be 
found in Appendix C 1-9. 
           V.1.1. Trends found in Sb(Ph)4 cyanoximates crystal structure. All tetraphenyl 
organoantimony(V) cyanoximates have an Sb(V) core that adopts a distorted trigonal bipyramid 
geometry. This can be seen in every Oak Ridge Thermal Ellipsoids Program (ORTEP) diagram 
shown in this chapter. Coordination polyhedra of organoantimony(V) cyanoximates are similar 
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to those as previously determined compounds Sb(Ph)4OCH3 and Sb(Ph)4OH referenced.
60 Some 
peculiarities of the pentavalent coordination can be described for each crystal structure 
determined in this work. Thus, there are three phenyl rings in the equatorial position of the 
distorted trigonal bipyramid, where they adopt the most sterically favored three blade propeller-
type configuration. These equatorial phenyl rings are also slightly tilted towards the coordinated 
monodentate cyanoxime ligand bound in the axial position to the Sb(V) atom. 
           In total, nine crystal structures of organoantimony(V) cyanoximtes were determined. In 
six cases, there were only one molecule located in the asymmetric unit (ASU), while in three 
cases we observed multiple crystallographically independent molecules in the ASU. All 
determined and finalized crystal structures were registered at the world-wide Cambridge 
Crystallographic Data Centre (CCDC) in England. Quality of data has been verified in Holland 
by using the PLATON checkCIF program and results are present in Appendix C. 
           V.1.2. Crystal structure of Sb(Ph)4(ACO). The Sb(Ph)4(ACO) crystal and refinement 
data are presented in Table 4. The coordination compound crystallized as a clear colorless block-
like specimen. The cyanoxime moiety adopts the trans-anti conformation with respect to the 
position of the N-O of the oxime and pyridyl ring along the C2-C3 bond (Figure 23).The trans-
anti configuration agreed with previous determination of previously described Sb(Ph)4(ACO) 
crystal structure determined in.60  The ACO- oxime anion is planar, signifying no dihedral angle, 
and in agreement with the previously mentioned publication and other data for this ligand. In this 
study a low temperature structure was the same. This crystal structure is stabilized by H-bonding 
between one of the amide’s Hydrogens and the cyanoximes N from N-O-Sb (Figure 24). The 
geometry of the coordination polyhedron of the Sb(V) atom was a distorted trigonal bipyramid 
coordinated was observed (Figure 25). The cyano group of the oxime is linear with atoms C1 - 
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C2 - N2 = 175.9° (Table 5). Bond distances for cyano group C2 - N2 = 1.144 Å, oxime group 
N1-O1 = 1.337 Å, and C1 - N1 = 1.278 Å. CCDC 2011862 contains the supplementary 
crystallographic data for this compound found in Appendix C-1.  
 
 
Figure 23. Molecular structure and numbering scheme of principal atoms in the crystal structure 
of Sb(Ph)4(ACO). An ORTEP representation at 50% thermal ellipsoid probability. H-atoms 
omitted for clarity. 
 
 
Figure 24. Two least obstructed views of Sb(Ph)4(ACO) showing structure stabilization through 












Crystal size, mm 0.188 mm x 0.127 mm x 0.104 mm
Temperature, K 120(2)
Crystal system monoclinic
Space group, #  P 1 21/c 1
Unit cell, Å,° a = 14.8336(8)           α = 90
b = 9.9060(6)             β = 112.7130(10)
c = 17.3977(10)         γ = 90












Θ range, ° 1.49 to 33.02°
Index ranges -22 ≤ h ≤ 22
-14 ≤ k ≤ 15
-26 ≤ l ≤ 26
Structure solution
Reflections collected 38365
Indpendent reflections 8465 [R(int) = 0.0278]
Completeness to Θ, (%) 33.02° (95.0)
Aborption correction Multi-scan
Tmax  and Tmin 0.880 and 0.683
Refinement method




Final R indices [I > 2σ(I)] R1 = 0.0288
wR2 = 0.0636
R indices (all data) R1 = 0.0391 
wR2 = 0.0726






 (%) 1507.5 (63.92)
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Figure 25. A, analysis of the angles of the coordination polyhedron of Sb(V) in Sb(Ph)4(ACO). 
B, analysis of planarity between Sb(V) core and equatorial ipso carbons of the phenyl rings. 
 
Bond length (Å) Valence angle (°)
C1 - C2 = 1.441(3) O1 - N1 - C1 =  116.81(17)
N2 - C2 = 1.144(3) N1 - C1 - C2 =  121.02(19)
C1 - C3 = 1.498(3) N1 - C1 - C3 =  119.22(19)
C3 - O2 = 1.227(3) C1 - C2 - N2 =  175.9(3)
C3 - N3 = 1.339(3) C1 - C3 - N3 =  114.25(19)
O1 - N1 =  1.337(2) C1 - C3 - O2 =  121.0(2)
N1 - C1 =  1.278(3) N3 - C3 - O2 =  124.8(2)
Sb1 - O1 = 2.2529(14) C4 - Sb1 - O1 =   81.29(7)
C10 - Sb1 - O1 =  176.48(6)
C16 - Sb1 - O1 =    84.74(7)
C22 - Sb1 - O1 =  83.43(7)
C10 - Sb1 - C4 =  95.71(8)
C16 - Sb1 - C4 = 118.80(8)
C22 - Sb1 - C4 = 120.76(8)
C16 - Sb1 - C10 =   98.35(8)
C16 - Sb1 - C22 = 116.21(8)




           V.1.3. Crystal structure of Sb(Ph)4(2PCO). The Sb(Ph)4(2PCO) crystal and refinement 
data are presented in Table 6. The coordination compound crystallized as a colorless block-like 
specimen (Figure 26). The cyanoxime moiety adopts the trans-anti conformation with respect to 
the position of the N-O of the oxime and pyridyl ring along the C2-C3 bond (Figure 27). The 
trans-anti configuration does not agree with that of the  free cyanoxime H(2PCO) previously 
described.112 H(2PCO) and its Fe and Ni complexes.113 The oxime anion is nonplanar as there 
are two planes: a) with the main cyanoxime structure O1-N1-C1-C2-N2, and b) the pyridyl ring. 
These planes have a dihedral angle of 22.63°. This crystal structure is stabilized through 
intramolecular short electrostatic contact from one of the hydrogen and the π-system of one of 
the equatorial phenyl rings (Figure 28). The cyano group of the oxime is linear with atoms C1 - 
C2 - N2 = 179.3° (Table 7). Bond distances for cyano group C2 - N2 = 1.147 Å, oxime group 
N1-O1 = 1.336 Å, and C1 - N1 = 1.301 Å. The CCDC number for this compound is 2011861. 
Quality of the obtained structure is shown in Appendix C-2. 
 
 
Figure 26. Video microscope image of the crystal of Sb(Ph)4(2PCO) with indexed faces. 
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Crystal size, mm 0.084 x 0.127 x 0.171
Temperature, K 120(2)
Crystal system Monoclinic
Space group, # P 1 21/n 1
Unit cell, Å,°            a =  12.6032(8)            α = 90
           b = 14.4421(9)             β = 104.9640(10)
           c = 14.6699(9)             γ = 90












Θ range, ° 1.90 to 30.57°
Index ranges -18 ≤ h ≤ 18
-20 ≤ k ≤ 20 
-20 ≤ I ≤ 20
Structure solution
Reflections collected 41038
Indpendent reflections 7900 [R(int) = 0.0675]
Completeness to Θ, (%) 30.57° (99.7)
Aborption correction Multi-scan






Final R indices [I > 2σ(I)] R1 = 0.0445
wR2 = 0.0900
R indices (all data) R1 = 0.0778
wR2 = 0.1098








Table 7.  Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in 
Sb(Ph)4(2PCO).  
Bond length (Å) Valence angle (°) 
Cyanoxime: 
C1 - N1 = 1.301(4) C1 - N1 - O1 = 113.3(3) 
C1 - C3 = 1.473(5) C1 - C2 - N2 = 179.3(4) 
C2 - N2 = 1.147(5) C2 - C1 - C3 = 118.6(3) 
C3 - N3  = 1.338(4) C7 - N3 - C3 = 117.4(3) 
C7 - N3 = 1.348(5) N1 - C1 - C3 = 120.4(3) 
N1-O1 = 1.336(4) C2 - C1 - N1 = 121.0(3) 
Metal Center: 
Sb - O1 = 2.226(2) C8 - Sb1 - O1 = 176.09(11) 
 C14 - Sb1 - O1 = 81.88(11) 
 C20 - Sb1 - O1 = 86.01(11) 
 C26 - Sb1 - O1 = 94.14(12) 
 C14 - Sb1 - C8 = 96.48(12) 
 C20 - Sb1 - C8 = 97.90(13) 
 C26 - Sb1 - C8 = 94.14(12) 
 C20 - Sb1 - C14 = 115.26(13) 
 C20 - Sb1 - C26 = 118.21(13) 




Figure 27. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU 
Sb(Ph)4(2PCO) showing the numbering of principal atoms. H-atoms are omitted for clarity.  
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Figure 28. Structure of intramolecular stabilization through electrostatic contact of equatorial 
phenyl ring π-system and pyridyl hydrogen of Sb(Ph)4(2PCO). Involved atoms are expressed in a 
space-filling mode. 
 
           V.1.4. Crystal structure of Sb(Ph)4(3PCO). The Sb(Ph)4(3PCO) crystal and refinement 
data are presented in Table 8. The coordination compound crystallized as a colorless block-like 
specimen. The cyanoxime moiety adopts the trans-anti conformation with respect to the position 
of the N-O of the oxime and pyridyl ring along the C2-C3 bond (Figure 29). The trans-anti 
configuration agrees with previous determination of the free cyanoxime H(3PCO) previously 
described.112  The oxime anion is completely planar in this structure. This crystal structure is 
stabilized through intramolecular H-bonding from one of the hydrogens from the pyridyl ring 
and N1 of the cyanoxime (Figure 30). The cyano group of the oxime is linear with atoms C1 - C2 
- N2 = 177.3° (Table 9). Bond distances for cyano group C2 - N2 = 1.134 Å, oxime group N1-
O1 = 1.339 Å, and C1 - N1 = 1.295 Å. The geometry of the coordination polyhedron and off 
plane trigonal distance of the distorted trigonal bipyramid polyhedron of Sb(Ph)4(3PCO) can be 
seen in Figures 31-32.The CCDC number assigned for this structure is 201180, while the 




Figure 29. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU 




Figure 30. The least obstructed view of the ASU of Sb(Ph)4(3PCO) showing intramolecular 












Crystal size, mm 0.086 x 0.103 x 0.144 
Temperature, K 296(2)
Crystal system Triclinic
Space group, # P -1
Unit cell, Å,° a =  10.0228(4)           α = 69.3240(10)     
b = 10.498(4)              β = 72.0860(10)
c = 13.8258(5)            γ = 83.9710












Θ range, ° 1.65 to 28.00°
Index ranges -13 ≤ h ≤ 13
-13 ≤ k ≤ 13 
-18 ≤ I ≤ 18
Structure solution
Reflections collected 18032
Indpendent reflections 6218[R(int) =0.0263
Completeness to Θ, (%) 28.00(99.9)
Aborption correction Multi-scan






Final R indices [I > 2σ(I)] R1 = 0.0242
wR2 = 0.0567
R indices (all data) R1 = 0.0278
wR2 = 0.0585






 (%) 811.86 (62.92)
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Figure 31. Geometry of the pentavalent antimony complex Sb(Ph)4(3PCO), showing a distorted 
trigonal bipyramid polyhedron coordination. Important bond lengths (A) and angles (B) of 
coordination are shown. 
 
 
Bond length (Å) Valence angle (°)
C1 - N1 = 1.295(3) C1 - N1 - O1 =  115.64(17)
C1 - C3 = 1.466(3) C1 - C2 - N2 = 177.3(3)
C2 - N2 = 1.134(3) C2 - C1 - C3 = 119.55(17)
C6 - N3  = 1.318(4) C7 - N3 - C6 = 116.6(2)
C7 - N3 = 1.318(3) N1 - C1 - C3 = 119.33(18)
N1-O1 = 1.339(2) C2 - C1 - N1 = 121.11(19)
Sb - O1 = 2.226(2) C8 - Sb1 - O1 = 85.79(6)
C14 - Sb1 - O1 =  83.77(6)
C20 - Sb1 - O1 =  86.72(6)
C26 - Sb1 - O1 = 177.39(6)
C14 - Sb1 - C8 = 123.50(7)
C20 - Sb1 - C8 = 118.71(7)
C26 - Sb1 - C8 =  92.04(7)
C20 - Sb1 - C14 = 115.89(7)
C20 - Sb1 - C26 = 95.61(7)






Figure 32. View of the off-plane distance in the distorted trigonal-bipyramid coordination 




           V.1.5. Crystal structure of Sb(Ph)4(4PCO). The Sb(Ph)4(4PCO) crystal and refinement 
data are presented in Table 10. The coordination compound crystallized as a clear, colorless 
block-like specimen. The oxime anion is completely planar (Figure 33). Crystal packing of this 
crystal structure is stabilized by H-bonding from two separate hydrogens of two phenyl rings to a 
phenyl ring and pyridyl π-system (Figure 34). The cyano group of the oxime is linear with atoms 
C1 - C2 - N2 = 177.10° (Table 11). Bond distances for cyano group C2 - N2 = 1.146 Å, oxime 
group N1-O1 = 1.339 Å, and C1 - N1 = 1.304 Å. The CCDC number for this compound is 






Figure 33. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU 





 Figure 34. Packing of two structures of Sb(Ph)4(4PCO) showing stabilization short electrostatic 
contact between the centers of the 4-pyridyl centroid and phenyl rings with phenyl hydrogens.  
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Crystal size, mm 0.212 x 0.228 x 0.700
Temperature, K 120(2)
Crystal system Monoclinic 
Space group, # P 1 21/n 1
Unit cell, Å,° a =  15.3351(10)          α = 90
b = 9.7845(6)               β = 108.4590(10)
c = 18.0770(11)           γ = 90












Θ range, ° 1.52 to 28.00°
Index ranges -20 ≤ h ≤ 20
-12 ≤ k ≤ 12
-23 ≤ l ≤ 23
Structure solution
Reflections collected 33177
Indpendent reflections 6190 [R(int) = 0.0197]
Completeness to Θ, (%) 28.00(100)
Aborption correction Multi-scan






Final R indices [I > 2σ(I)] R1 = 0.0213
wR2 = 0.0543
R indices (all data) R1 = 0.0236
wR2 = 0.0556






 (%) 1640.11 (63.74)
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           V.1.6. An unexpected result: crystal structure of Sb(Ph)3(ECO) μ-oxo-dimer. With 
some mistakes in the world of science, sometimes a surprise can occur with failure. This is the 
case with one of my early synthesis with Sb(Ph)4(ECO). By misjudging how much water was 
needed for the basic solution of K2CO3 during a preparation of Ag(3PCO), it ended up 
hydrolyzing Sb(Ph)4(ECO) into the [Sb(Ph)3(ECO)]2 μ-oxo-dimer which was later discovered 
after solving its crystal structure (Figure 35). There is a trans-effect of the coordinated oxime that 
facilitates addition of a hydroxo-group to the Sb(V) core (Figure 36A) followed by the 
dimerization of the triphenyl(V) hydroxide with elimination of water (Figure 36B). 
Stereospecific reactions with substitutions in the trans- position are common in inorganic and 
organometallic chemistry, and well documented in chemistry of Pt(II) and other kinetically inert 
metal centers. 
Bond length (Å) Valence angle (°)
C1 - N1 = 1.304(2) C1 - N1 - O1 =  113.82(13)
C1 - C3 = 1.470(2) C1 - C2 - N2 = 177.10(17)
C2 - N2 = 1.146(2) C2 - C1 - C3 = 118.60(13)
C5 - N3  = 1.339(2 C6 - N3 - C5 = 115.71(15)
C6 - N3 = 1.339(2) N1 - C1 - C3 = 120.33(14)
N1-O1 = 1.3390(17) C2 - C1 - N1 = 121.11(19)
Sb - O1 = 2.226(2) C8 - Sb1 - O1 = 84.25(5)
C14 - Sb1 - O1 = 178.65(5)
C20 - Sb1 - O1 = 82.58(5)
C26 - Sb1 - O1 = 84.37(5)
C14 - Sb1 - C8 = 96.82(6)
C20 - Sb1 - C8 = 121.08(6)
C26 - Sb1 - C8 = 117.11(6)
C20 - Sb1 - C14 = 97.57(6)
C20 - Sb1 - C26 = 118.25(6)




           For the crystal structure determination, a clear colorless, prism-like specimen was 
selected. The Sb(Ph)3(ECO) oxo-dimer crystal and refinement data are presented in Table 12. It 
was a surprise to find out the formation of an oxygen-bridging dimeric system. This μ-oxo-
bridge is linear as the angle of Sb1 - O1BR - Sb2 = 180.0° (Table 13). One of the interesting 
features about this structure is the anionic oxime moieties are completely planar. The cyano 
group is linear C1 - C2 - N2 = 177.43 Å . Bond lengths for the cyano group were C2 - N2 = 
1.145 Å, oxime group N1-O1 = 1.337 Å, and C1 - N1 = 1.299 Å. As for both Sb-O bond lengths 
that are incorporated into the oxo-bridge Sb1-OBr and Sb2-OBr were 1.95274 and 1.95276 Å, 
respectively (Table 13). The CCDC assigned number is 2012154 for this compound. The 
checkCIF report is present in Appendix C-5. 
 
 
Figure 35. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU in the 
structure of Sb(Ph)3(ECO) μ-oxo-dimer showing the numbering of principal atoms. H-atoms are 


























































































Figure 36. Scheme of suggested path for hydrolysis, A, and the dimerization, B, of 
organoantimony(V) in moist conditions. 
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Crystal size, mm 0.180 x 0.228 x 0.984
Temperature, K 120(2)
Crystal system Triclinic 
Space group, # P -1
Unit cell, Å,° a = 9.1829(9)              α = 111.9570(10)
b = 10.0829(10)          β = 103.200(2)
c = 13.4714(16)          γ = 95.4050(10)












Θ range, ° 1.70 to 30.51°
Index ranges -13 ≤ h ≤ 13
-14 ≤ k ≤ 14
-19 ≤ l ≤ 19
Structure solution
Reflections collected 17209
Indpendent reflections 6688 [R(int) = 0.0159
Completeness to Θ, (%) 30.51° (99.2)
Aborption correction Multi-scan






Final R indices [I > 2σ(I)] R1 = 0.0188
wR2 = 0.0433
R indices (all data) R1 = 0.0206 
wR2 = 0.0447






 (%) 677.92 (61.42)
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Table 13. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in 
Sb(Ph)3(ECO) oxo-dimer. BR denotes the bridge oxygen connecting the dimer. 
 
Bond length (Å) Valence angle (°) 
Cyanoxime: 
C1 -C2 = 1.441(2) N2 - C2 - C1 = 177.43(17) 
N2 - C2 = 1.145(2) C1 - N1 - O1 = 115.11(12) 
N1 - C1 = 1.2993 (18) N1 - C1 - C2 = 122.83(13) 
N1 - O1 = 1.3370 (15)  
C1 - C3 = 1.488(2)   
Metal Center: 
O1BR-Sb1 = 1.95274(16) Sb1 - O1BR - Sb2 = 180.0 
O1BR-Sb2 = 1.95276 (16)  




           V.1.7. Crystal structure of the monomeric Sb(Ph)4(ECO). Opposing the failure that 
gave rise to the μ-oxo-dimer, the monomer of Sb(Ph)4(ECO) was successfully prepared and 
crystallized. The crystalline compound is also a clear colorless block-like specimen. Crystal 
structure of this compound is different and interesting because contrary to earlier described 
structures, it contains two independent molecules in the ASU (Figure 37). The crystal packing 
can be seen in Figure 38. Both molecules A and B cannot be superimposed by any symmetry 
operations in this group. Therefore, they are called crystallographically independent molecules. 
The Sb(V) atom is in a special position and is located directly on the only symmetry element 
present in the crystal - a gliding plane (Figure 39). 
           Regarding the configuration of the oxime ligand, is adopts trans-anti conformation in both 
structures. Structure and refinement data of the monomer crystal structure is shown in Table 14. 
Molecule A has linear cyano group C1A - C2A - N2A = 179.2° (Table 15). Molecule B adopts a 
linear cyano group as well with C1B - C2B - N2B = 177.5° (Table 16). Bond lengths for the 
cyano group were C2A - N2A = 1.144 Å, oxime group N1A-O1A = 1.324 Å, and C1A - N1A = 
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1.308 Å for molecule A, and C2B - N2B = 1.144 Å, oxime group N1B-O1B = 1.323 Å, and C1B 
- N1B = 1.302 Å for molecule B. Both independent molecules have the ECO- anion with a planar 
configuration cyanoximes core structure. As an interesting peculiarity, we will mention that the 
C-O-C atoms of the ethoxy-group are ion plane with only the CH3 group being out of plane. We 
may attribute this behavior to the demands of crystal packing. This structure has received the 
CCDC number 2012153 and quality of the structure has been validated in the checkCIF report 





Figure 37. An ORTEP drawing at 50% thermal ellipsoids probability level for the two 
crystallographically independent molecules in the ASU of Sb(Ph)4(ECO) monomer showing the 










Table 15.  Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center 




Table 16. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in 




Bond length (Å) Valence angle (°)
C1A - N1A =  1.308(6) C1A - N1A - O1A =  116.0(4)
C1A - C3A = 1.483(7) C1A - C2A - N2A =  179.2(6)
C2A - N2A =  1.144(8) C2A - C1A - C3A = 118.0(4)
C3A - O3A  = 1.352(8) C3A - O3A - C4A =  115.9(5)
C4A - O3A =  1.456(7) N1A - C1A - C3A = 119.3(5)
N1A-O1A = 1.324(5) C2A - C1A - N1A =  122.7(5)
Sb1A - O1A =  2.373(3) C6A - Sb1A - O1A = 83.06(17)
C12A - Sb1A - O1A = 174.59(15)
C18A - Sb1A - O1A = 80.13(15)
C24A - Sb1A - O1A = 84.05(16)
C12A - Sb1A - C6A =  96.4(2)
C18A - Sb1A - C6A =  125.3(2) 
C24A - Sb1A - C6A = 114.09(18)
C18A - Sb1A - C12A = 95.91(18)
C18A - Sb1A - C24A =  115.29(18)
C24A - Sb1A - C12A = 101.03(19)
Cyanoxime:
Metal Center:
Bond length (Å) Valence angle (°)
C1B - N1B = 1.302(6) C1B - N1B - O1B =  115.4(4)
C1B - C3B = 1.488(7) C1B - C2B - N2B = 177.5(6)
C2B - N2B = 1.144(8) C2B - C1B - C3B =  117.8(4)
C3B - O3B  = 1.338(7) C3B - O3B - C4B =  115.7(5)
C4B - O3B = 1.460(7) N1B - C1B - C3B =  120.5(5)
N1B-O1B = 1.323(5) C2B - C1B - N1B = 121.7(4)
Sb1B - O1B = 2.327(3) C6B - Sb1B - O1B =  82.70(16)
C12B - Sb1B - O1B =  175.94(17)
C18B - Sb1B - O1B =  81.21(16)
C24B - Sb1B - O1B = 83.28(17)
C12B - Sb1B - C6B = 100.23(19)
C18B - Sb1B - C6B = 115.2(2)
C24B - Sb1B - C6B = 115.80(19)
C18B - Sb1B - C12B =  94.96(19)
C18B - Sb1B - C24B = 123.82(19)





Figure 38. Two different views of the crystal packing in the unit cell in the structure Sb(Ph)4(ECO) 
molecule A (red) and molecule B (purple). 
 
 
Figure 39. Two views of the crystal packing in the unit cell Sb atom on a special position gliding 
plane. Independent molecules A and B are drawn in different colors for clarity. 
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V.1.8. Crystal structure of Sb(Ph)4(MCO). For structure determination of this compound a 
clear, colorless, block-like crystal was selected. Similarly to the previous structure, in the 
structure of Sb(Ph)4(MCO) it was found to include two crystallographically independent 
molecules in the ASU which we also labeled as A and B (Figure 40) . The crystal and refinement 
data for this structure are presented in Table 17. Different from most of the solved crystal 
structures, around half of the hydrogen atoms were found isotropically, the rest were attached 
based on hybridization states with carbon atoms. The cyanoximes moieties of molecules A and B 
are nonplanar. The morpholyl groups in molecules A and B adopted the chair conformation for 
stability. In both cases, the cyanoximes moieties in molecules A and B are heavily non-planar 
and their dihedral angles between the cyanoxime and amide fragments are 43.99° and 47.31° for 
A and B, respectively. This situation is different from other previously described Sb(V)-
cyanoximates with ACO- and isomeric pyridyl-cyanoximes. 
This compound is an example of a classical molecular crystallography, which only relies 
on van-der-Waals interactions in crystal packing. Molecules A and B have linear cyano group 
Bond lengths for the cyano group were C2A - N2A = 1.141 Å, oxime group N1A-O1A = 1.353 
Å, and C1A - N1A = 1.289 Å for molecule A (Figure 41), and C2B - N2B = 1.157 Å, oxime 
group N1B-O1B = 1.339 Å, and C1B - N1B = 1.289 Å with molecule B (Table 18-19). The 
CCDC has assigned the number 2012156 for this structure. Quality of crystal data for this 

















Crystal size, mm 0.120 X 0.120 X 0.140
Temperature, K 100(2)
Crystal system Monoclinic
Space group, # P 1 21/c 1
Unit cell, Å,° a =  17.6451(4)          α = 90
b = 10.8777(3)           β = 94.8360(10)
c = 28.3876(7)           γ = 90












Θ range, ° 1.16 to 26.52°
Index ranges -22 ≤ h ≤ 22
-13 ≤ k ≤ 13 
-35 ≤ I ≤ 35
Structure solution
Reflections collected 75269
Indpendent reflections 11251 [R(int) = 0.0612]
Completeness to Θ, (%) 26.52° (99.8)
Aborption correction Multi-scan
Tmax  and Tmin 0.8840 and 0.8670
Refinement method




Final R indices [I > 2σ(I)] R1 = 0.0447
wR2 = 0.1034
R indices (all data) R1 = 0.0584
wR2 = 0.1109









Figure 40. Two independent molecules in the ASU of the structure of Sb(Ph)4(MCO); and ORTEP 
drawing at 50% thermal ellipsoids probability level. Principal atoms are labeled, with H atoms are 
omitted for clarity.  
 
Table 18. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in 
the first independent molecule A, in the ASU of Sb(Ph)4(MCO). 
 
 
Bond length (Å) Valence angle (°)
C1A - N1A = 1.289(5) C1A - N1A - O1A =  114.8(4)
C1A - C3A = 1.496(6) C1A - C2A - N2A = 178.6(6)
C2A - N2A =   1.141(6) C2A - C1A - C3A =  115.2(4)
C3A - O2A  =  1.240(5) C1A - C3A - O2A =  116.6(4)
C3A - N3A =  1.337(6) N1A - C1A - C3A =  122.2(4)
N1A-O1A =  1.353(5) C2A - C1A - N1A =  122.3(4)
O2A - C3A - N3A =  122.6(5)
Sb1A - O1A = 2.260(3) C8A - Sb1A - O1A =  83.12(13)
C14A - Sb1A - O1A =  177.76(12)
C20A - Sb1A - O1A =  83.17(13)
C26A - Sb1A - O1A = 85.89(13)
C14 - Sb1A - C8A = 97.40(16)
C20A - Sb1A - C8A = 113.89(16)
C26A - Sb1A - C8A = 123.77(15)
C20A - Sb1A - C14A =   94.64(15)
C20A - Sb1A - C26A = 119.19(16)




Table 19. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in 




Figure 41. Molecular structure and labeling of principal atoms in the structure of Sb(Ph)4(MCO) 
molecule A on the left, and some selected important bond lengths on the right. 
Bond length (Å) Valence angle (°)
C1B - N1B = 1.289(5) C1B - N1B - O1B =  115.3(4)
C1B - C3B =  1.493(7) C1B - C2B - N2B = 178.4(5)
C2B - N2B =  1.157(6) C2B - C1B - C3B =  117.1(4)
C3B - O2B  = 1.233(5) C1B - C3B - O2B =  118.4(4)
C3B - N3B =  1.343(6) N1B - C1B - C3B =  119.1(4)
N1B-O1B = 1.339(5) C2B - C1B - N1B = 123.3(4)
O2B - C3B - N3B =  123.2(5)
Sb1B - O1B = 2.241(3) C8B - Sb1B - O1B = 81.09(13)
C14B - Sb1B - O1B = 175.06(13)
C20B - Sb1B - O1B =   86.79(13)
C26B - Sb1B - O1B = 84.06(14) 
C14B - Sb1B - C8B =  94.05(15)
C20B - Sb1B - C8B =  120.45(16)
C26B - Sb1B - C8B =  116.21(16)
C20B - Sb1B - C14B = 96.53(15)
C20B - Sb1B - C26B = 120.11(15)




V.1.9. Crystal structure of Sb(Ph)4(TCO), two polymorphs. There were two different 
polymorphs of the Sb(Ph)4(TCO) obtained from the system involving the TCO
- anion and 
Sb(Ph)4
+ cation: polymorph 1 and polymorph 2. The first contains two independent molecules in 
the ASU and crystallizes in the standard P21/ c monoclinic space group (Table 20). The second 
one contains eight independent molecules in the ASU and crystallizes in the Cc monoclinic space 
group (Table 21). The difference between these two systems generating 2 different polymorphs 
are the conditions of crystallization. Polymorph 1 was obtained after slow evaporation of the 
solvent CH3CN in a charged desiccator with paraffin. Utilizing this method of crystallization, 
crystals were obtained in a week. Polymorph 2 was collected through means of vapor diffusion 
when ether vapors assisted crystallization by pushing the compound from the CH3CN solution to 
the walls of the inner tube. The second method, using vapor diffusion, afforded suitable crystals 
for the X-ray analysis of crystals over a two-month period for crystal growth. 
 Polymorph 1. The coordination compound crystallized as a clear, yellow-bronze, plate-
like specimen (Figure 42). The Sb(Ph)4(TCO) was discovered to have in both cases unusual 
geometry of the thio-oxime. In polymorph 1 there are two co-crystallized diastereomers, trans-
anti and trans-syn, in the asymmetric unit (ASU) in the structure (Figure 43).  The crystal and 
refinement data of this complex is shown in Table 20. The ratio between both diastereomers was 
found to be 81.7 and 18.3%, respectively (Figure 44). In both diastereomers, the TCO- 
cyanoxime ligand are practically planar. In the case of the trans-anti isomer, the first plane 
consists of every atom in the cyanoxime moiety except the amide electron withdrawing group 
(C3-N3-H3B) giving a small dihedral angle of 7.42°. The trans-syn isomer is a bit different in 
terms of what creates the planes of non-planarity. The first plane consists of O1A-N1A-N2A-
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C2A-C1A-C3A, the second follows with the sulfur and nitrogen of the amide (S1A-N3A-H3A1). 
These two planes intersect forming a dihedral angle of 17.27°.  
           Another representation of the Sb(V) coordinated distorted trigonal bipyramid polyhedron 
can be seen in Figure 45. The trans-anti isomer has a linear cyano group C1 - C2 - N2 = 175.6° 
(Table 21). The trans-syn isomer owns a linear cyano group with C1a - C2a - N2a = 173.0° 
(Table 21). Bond lengths for the cyano group were C2 - N2 = 1.140 Å, oxime group N1-O1 = 
1.345 Å, and C1 - N1 = 1.266 Å for the trans-anti diastereomer, and C2a - N2a = 1.15 Å, oxime 
group N1a-O1a = 1.273 Å, and C1a - N1a = 1.33 Å with the syn diastereomer. This structure 
















Crystal size, mm 0.142 x 0.148 x 0.167
Temperature, K 120(2)
Crystal system Monoclinic 
Space group, # 	P 1 21/c 1
Unit cell, Å,° a =  14.6709(7)         α = 90
b = 9.8468(5)            β = 111.9940(10)
c = 18.3414(9)          γ = 90












Θ range, ° 	2.30 to 27.20°
Index ranges -18 ≤ h ≤ 18
-12 ≤ k ≤ 12
-23 ≤ l ≤ 23
Structure solution
Reflections collected 29603
Indpendent reflections 	5476 [R(int) = 0.0351]
Completeness to Θ, (%) 27.20(99.9)
Aborption correction Multi-scan
Tmax  and Tmin 0.8440 and 0.8210
Refinement method




Final R indices [I > 2σ(I)] R1 = 0.0308
wR2 = 0.0715
R indices (all data) R1 = 0.0397
wR2 = 0.0764






 (%) 1614.42 (65.71)
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Table 21.  Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center 
in the co-crystallized diastereomers of polymorph 1 of Sb(Ph)4(TCO) polymorph 1, trans-anti 




Bond length (Å) Valence angle (°)
C1 - N1 = 1.266(5) C1 - N1 - O1 =  113.9(17)
C1 - C3 = 1.480(5) C1 - C2 - N2 = 175.6(5)
C2 - N2 =  1.140(7) C2 - C1 - C3 =  119.2(3)
C3 - S1  = 1.636(5) C1 - C3 - S1 =  121.9(3)
C3 - N3 =  1.336(5) N1 - C1 - C3 =  118.9(4)
N1-O1 = 1.345(4) C2 - C1 - N1 = 121.9(3)
S1 - C3 - N3 =  124.1(3)
Sb1 - O1 = 2.304(2) C4 - Sb1 - O1 =   84.23(10)
C10 - Sb1 - O1 =  176.86(9)
C16 - Sb1 - O1 =   83.09(10)
C22 - Sb1 - O1 = 79.91(10)
C10 - Sb1 - C4 = 97.81(10)
C16 - Sb1 - C4 = 116.60(10)
C22 - Sb1 - C4 = 122.04(10)
C16 - Sb1 - C10 =  98.06(10)
C16 - Sb1 - C22 = 116.18(10)
C22 - Sb1 - C10 =  96.97(10)
C1a - N1a = 1.33(2) C1a - N1a - O1a =  113.9(17)
C1a - C3a = 1.44(3) C1a - C2a - N2a = 173.(2)
C2a - N2a = 1.15(3) C2a - C1a - C3a =   121.7(18)
C3a - S1a  = 1.82(3) C1a - C3a - S1a =  111.8(17)
C3a - N3a = 1.27(3) N1a - C1a - C3a =  128.(2)
N1a-O1a = 1.273(19) C2a - C1a - N1a = 109.9(19)
S1a - C3a - N3a = 123.1(16)
Sb1 - O1a = 2.370(14) C4 - Sb1 - O1a =  78.3(3)
C10 - Sb1 - O1a =  164.1(4)
C16 - Sb1 - O1a =   70.7(3)







Figure 43. Two co-crystallized diastereomers, trans-syn and trans-anti, of the structure of 
Sb(Ph)4(TCO) polymorph 1; an ORTEP drawing at 50% thermal ellipsoids probability level. 





Figure 44. Two least obstructed views of the two diastereomers of Sb(Ph)4(TCO) in the ASU 
representing H bonding stability between the amide hydrogen (N-H3a) and O1a. Ratios of 




Figure 45. Geometry of the pentavalent antimony complex Sb(Ph)4(TCO) diastereomers, showing 
a distorted trigonal bipyramid polyhedron coordination. Important bond lengths and angles of 
coordination are shown.  
 
Polymorph 2. This crystalline compound formed as yellow almost square plates. A 
specimen with dimensions of 0.080 mm x 0.110 mm x 180 mm was selected for crystallographic 
work. We assigned it as polymorph 2. Contrary to the previous polymorph the ASU of 
polymorph 2 contained eight individual molecules as only one diastereomer, trans-syn (Figure 
46). This is a unique occurrence, as the unit cell volume is incredibly larger, 19k Å3 compared to 
the previous 2.5k Å3 to be precise (Table 22)! With a Z value of 4, this contributes 32 molecules 
in one unit cell.  
           The lone diastereomer, trans-syn, stabilizes its structure through intramolecular H-
bonding between the one of the equatorial phenyl ring’s and amide’s hydrogen to the only 
oxygen from the cyanoxime (Figure 47). The numbering scheme in the structure consisted of A, 
B, C, D, E, F, H, and Q independent molecules. Representation of molecule Q will be used for 
bonds and angles as an example. Other seven individual molecules can be retrieved from the 
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CCCDC number 2012157 and seen in Appendix C-9. The diastereomer has a linear cyano group 
C1Q - C2Q - N2Q = 175.1° (Table 23). Bond lengths for the cyano group were C2Q - N2Q = 
1.151 Å, oxime group N1Q-O1Q = 1.315 Å, and C1Q - N1Q = 1.339 Å found in Table 23. Every 
individual molecule was found to be nonplanar in the cyanoxime anion. All of which had the 
same position of planes in the cyanoxime structure with the first plane being made up from N3-
C3-S1A from the thioamide. The second plane consisted of N2-C2-O1-N1-C1. All dihedral 
angles from each individual molecule can be found with some statistical analysis in Table 24. 
This table also includes the bond lengths of Sb-O and angles, followed by analysis of off-plane 
Sb(V) core distance from the 3 ipso equatorial carbons of the phenyl rings.   
 
 
Figure 46. Molecular structure and numbering scheme for principal atoms in the one of the eight 
individual molecules in the ASU for the structure Sb(Ph)4(TCO) polymorph 2. An adoption of the 














Color fluorescent light colorless
Crystal size, mm 0.080 x 0.110 x 0.180
Temperature, K 100(2)
Crystal system Monoclinic
Space group, # C 1 c 1
Unit cell, Å,° a =  24.517(4),         α = 90
b = 24.448(4),          β = 101.670(2)
c = 32.958(5),          γ = 90












Θ range, ° 1.19 to 29.48°
Index ranges -33 ≤ h ≤ 33
-33 ≤ k ≤ 33 
-45 ≤ I ≤ 43
Structure solution
Reflections collected 145367
Indpendent reflections 49604 [R(int) = 0.0558]
Completeness to Θ, (%) 29.48(94.3)
Aborption correction Multi-scan
Tmax  and Tmin 0.9120 and 0.8160
Refinement method




Final R indices [I > 2σ(I)] R1 = 0.0569
wR2 = 0.1386
R indices (all data)  R1 = 0.0691
wR2 = 0.1472






 (%) 12444.5 (64.3)
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Table 23. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in 
Sb(Ph)4(TCO) polymorph 2 of the 8




Table 24. Analysis of bond lengths, bond and dihedral angles of the eight independent molecules 
of the Sb(Ph)4(TCO) polymorph 2 ASU. 
 
 
Bond length (Å) Valence angle (°)
C1Q - N1Q = 1.339(13) C1Q - N1Q - O1Q =  118.2(9)
C1Q - C3Q = 1.486(15) C1Q - C2Q - N2Q =  175.1(11)
C2Q - N2Q =  1.151(14) C2Q - C1Q - C3Q =   118.3(9)
C3Q - S1Q  =  1.687(10) C1Q - C3Q - S1Q =  120.0(7)
C3Q - N3Q =  1.326(13) N1Q - C1Q - C3Q =  127.8(9)
N1Q - O1Q = 1.315(11) C2Q - C1Q - N1Q = 113.8(9)
S1Q - C3Q - N3Q =   123.1(9)
Sb1Q - O1Q = 2.430(7) C4Q - Sb1Q - O1Q =   176.6(3)
C10Q - Sb1Q - O1Q =  83.2(3)
C16Q - Sb1Q - O1Q =   81.4(3)
C22Q - Sb1Q - O1Q =  81.7(3)
C10Q - Sb1Q - C4Q = 99.7(4)
C16Q - Sb1Q - C4Q = 98.8(4)
C22Q - Sb1Q - C4Q = 95.3(4)
C16Q - Sb1Q - C10Q =  116.5(4)
C16Q - Sb1Q - C22Q =  117.9(4)





Figure 47. Structure of the Q (or 8th) different polymorph shown of Sb(Ph)4(TCO) with 
representation of H-bonding between the amide and phenyl hydrogen’s with the oxygen from the 
oxime moiety. 
 
V.2. Differential Scanning Calorimetry – Thermal Gravimetry Analysis (DSC/TGA) 
           This method was used to aseess compounds’ thermal stability and determine accurate 
phase transitions. The DSC-TGA analysis of the Sb(V) cyanoximates are described Table 25. A 
typical thermogram of the Sb(Ph)4(ECO) monomer shows an endothermicpeak of heat flow at 
144.7°C representing and endothermic effect due to melting point (Figure 48). Every other 
thermogram contributing to Table 25 can be found in Appendix B, Figures B-1 to B-6.  
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Figure 48. Traces of weight loss (green) and heat flow (blue for the Sb(Ph)4(ECO) monomer 
showing the melting point of the compound at 144°C followed by its decomposition.  
 
 
V.3. Vibrational Spectroscopy: Infrared Spectroscopy 
           Assignments of vibrations were completed on all synthesized organoantimony(V) 
cyanoximates and can be found in Table 26. For a majority of assignments referenced from,60, 112 
but for the low cm-1 bands for Sb-Ph vibrations literature 114, 115 were used.  
 
V.4. NMR Spectroscopy – 13C{1H} Results 
           All NMR spectra were recorded at room temperature for most of the organoantimony(V) 
cyanoximates except Sb(Ph)4(TDCO) and Sb(Ph)4(ACO). The 
13C{1H} chemical shifts of these 
complexes can be found in Tables 27-28 below, along with Figure 49 demonstrating labeling on 
phenyl ring. Chemical shifts were assigned based on common knowledge of chemical shifts, 
previous work completed in the Dr. Gerasimchuk research group. 102, 112, 116 The technique of 
13C{1H} NMR spectroscopy is very useful as it can determine co-crystallized diastereomers , syn 
and trans, by recognizing the difference in the electronic structures of individual conformations as 
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two sets of resonances.117 The less favorable conformation can be found as small satellite peaks 
close to the main signal, as there is a small difference in chemical shifts between the two isomers. 
13C{1H} NMR spectra can be used as a good approximation for the ratio between the two 
diastereomers and can be coupled with crystallography to clearly identify the percentages of said 
ratio.102 In the case of Sb(Ph)4(TCO), satellites were present in the spectra, with chemical shifts 
shown in Table 28. Further investigation with 13C{1H} chemical shifts of the organoantimony(V) 
cyanoximates, specifically the pyridylcyanoximates, 
 




Table 26. Assignment of important vibrational frequencies (cm-1) for synthesized organoantimony(V) cyanoximates. 
 
 
a X = sulfur atom (for TCO- and TDCO-), oxygen atom (for 2PCO-, 3PCO-, 4PCO-, ACO-, ECO-, MCO-). ox
 – oxime, pyr – pyridine 
 
 
C6H5 - group and Sb-Ph vibrations 
Compound ν (NH2) ν (C≡N) ν (C=X)
a
ν (C=N)pyr ν (C=N)ox ν (N-O) ρ (NH2) νas(C-H) y(ν′1g) v(ν8)
Sb(Ph)4(2PCO) - 2213 - 1589 1463 1016 - 3094 463, 433 689
Sb(Ph)4(3PCO) - 2218 - 1574 1473 1065 - 3051 459, 444 687
Sb(Ph)4(4PCO) - 2216 - 1590 1468 1114 - 3057 454, 442, 431 687
Sb(Ph)4(ACO) 3439, 3366 2222 1679 - 1478 1086 1580 3053 442 688
Sb(Ph)4(ECO) - 2217 1703 - 1477 1091 - 3052 458, 436 689
Sb(Ph)4(MCO) - 2223 1629 - 1497 1063 - 3061 443 690
Sb(Ph)4(TCO) 3465, 3341 2220 889 - 1583 1067 1618 3062 450 692
Sb(Ph)4(TDCO) - 2216 973 - 1524 1069 - 3066 445 688
vibrations in cyanoxime group 
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and free cyanoximes had a correlation with the acidity of the cyanoxime ligand. Figure 50 
demonstrates this relationship between the chemical shifts of the ipso carbon with pKa values. 
pKa values were found from previous literature.
117 This relationship can be explained by the four 
inequivalent carbons found on a phenyl ring. It is important to note the pyridylcyanoximates 
have different delocalization of electron density when compared to other aliphatic amide-/keto-
/ester-cyanoximes. Even though there are only three data points contributing to this linear 
relationship, it is still evident that the chemical shift of the ipso carbon is affected differently by 
each opposite axial cyanoxime ligand. 
 
Figure 49. General Structure representing the substitution patterns for the phenyl ring of 
organoanimtony(V) cyanoximates. L = ligands and Br, in the case of Sb(Ph)4Br. 
 
 
Table 27. Tabulated chemical shifts of 13C{1H} NMR spectroscopy for the Sb(Ph)4Br and 
organoantimony(V) cyanoximates’ equivalent phenyl rings. 
 
  Assigned peak signals (ppm) 
Compound ipso ortho meta para 
Sb(Ph)4Br 135.38 135.04 129.44 131.15 
Sb(Ph)4(ECO) 133.97 135.57 129.207 136.96 
Sb(Ph)4(2PCO) 135.79 135.65 129.02 130.54 
Sb(Ph)4(3PCO) 131.53 135.48 129.17 130.75 
Sb(Ph)4(4PCO) 129.01 135.54 129.12 149.69 
Sb(Ph)4(MCO) 134.9 135.59 129.2 130.9 
Sb(Ph)4(TCO) 133.45 135.34 129.52 131.29 
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Table 28. Tabulated values of chemical shifts oforganoantimony(V) cyanoximates in the 13C{1H} 
NMR spectra. 
 
Compound Structure δ (ppm) 
Sb(Ph)4(2PCO) 
 
C1 112.03                     
C2 132.38                      
C3 152.24                       
C4  148.79             
C5,C6,C7       135.79   
                    122.46  
                    118.24 
Sb(Ph)4(3PCO) 
 
C1 111.55                     
C2 128.52                      
C3 127.99                       
C4 149.05                 
C5  145.76                 
C6,C7            129.17;      
                    123.09 
Sb(Ph)4(4PCO) 
 
C1  111.56                     
C2 150.15                      
C3  140.05                       
C4,4'  118.24             





































Compound Structure δ (ppm) 
Sb(Ph)4(ECO) 
 
C1  112.03                     
C2 132.38                      
C3 152.24                       
C4             148.79             






C1 127.87                      
C2 111.54                      
C3 159.99                      
C4 46.60                   
C5                    43.02                     
C6            66.53 
C7              68.97 
Sb(Ph)4(TCO)               
trans-anti 
 
C1  110.92                     
C2 131.63                      
C3           190.01 
Sb(Ph)4(TCO)                
trans-syn 
 
C1  116.92                     
C2  136.38                      
C3          184.98                        
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Figure 50. Observed correlations between acidity of the free cyanoxime HL and chemical shift of 
the ipso carbon in NMR spectra of organoantimony(V) cyanoximates. 
 
V.5. UV-Visible Spectroscopy 
           All obtained organoanimtony(V) cyanoximates represent colorless compounds with the 
exception of Sb(Ph)4(TCO) and Sb(Ph)4(TDCO). Those exceptions are yellow colored, because 
the color of the thio-cyanoxime ligands. In the UV-visible spectra bands of π  π* transitions of 
the phenyl groups in all studied compounds at ~270 nm dominate the spectrum and there are no 
bands in the visible range of the spectrum. As we established earlier by the X-ray analysis, the 
cyanoxime ligands are bound to the Sb-atom in a monodentate manner. Compounds are soluble  
in a variety of solvents and form molecular solutions with no electrical conductivity. With a 
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research goal of performing biological activity studies in mind, it was important to assess the 
compounds’ integrity in solutions formed.  
           The method of UV-visible spectroscopy is a good tool for such this task, as anionic 
cyanoximes possess color. Therefore, there is a distinctive gain of color upon deprotonation of a 
protonated cyanoxime ligand, HL (L = ACO-, ECO-, 2PCO-, 3PCO-, 4PCO-, and MCO-) 
expressed in Figure 10. If our newly prepared Sb(Ph)4L compounds would undergo a solvolytic 
reaction or dissociate in solutions, then a color will appear shown as in Figure 51. The yellow, 
orange, or pink color of the cyanoximes anions originates from n  π* transition that is sensitive 























colorless                                                                                                          yellow / pink colored
solvent or T
 
Figure 51. Representation of the color gain of solutions of organoantimony(V) cyanoximates in 
the case of the compounds covalent integrity breaking down. 
 
           We performed recordings of the UV-visible spectra of colorless organoantimony(V) 
cyanxoimates in DMSO at room temperature, increasing up to 90°C in 10° intervals. Results 
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evidenced the absence of appreciable ionization of cyanoximes in solutions even at elevated 
temperatures (Figure 52 and 53). Therefore, all observed in biological studies effects can be 
associated with the molecular structure of the parent compound Sb(Ph)4L ( L = studied 
cyanoximes anion) and not to separate Sb(Ph)4
+ and L- ions. Of course, there are metabolic 
processes using biochemical interactions with degradation of our Sb(Ph)4L in microorganisms, 
but these investigations were out of the scope of current work. 
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Figure 52. An overlay of fragments of the UV-visible spectra of SbPh4(2PCO) in DMSO at 





Figure 53. An overlay of fragments of the UV-visible spectra of SbPh4(4PCO) in propionitrile at 
different temperatures, representing reversible equilibrium of covalent to ionic bonding of Sb(V) 
complex. 
 
V.6. Antimicrobial Studies  
           These assays were performed by Prof. Marianna Patrauchan and her research group, 
except the preparation of soaked 100% disks, which was prepared by me. The compounds 
selected for each assay are explained below in each sub-chapter of results. Minimal inhibition 
concentration (MIC) samples were dissolved DMSO solutions of the compounds selected prior 
to testing. The results for the two sets of inhibition zone measurements and single set of minimal 
inhibition concentration (MIC) assays are described below. 
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           V.6.1. First set of inhibition measurements on solid media. Initial compounds selected 
for susceptibility tests were: Sb(Ph)4(ACO), Sb(Ph)4(ECO) monomer, Sb(Ph)4(TCO), and 
Sb(Ph)4(TDCO). These compounds were tested against gram-negative strains Escherichia coli 
strain S17 and Pseudomonas aeruginosa strain PAO1, alongside gram-positive Methicillin-
resistant Staphylococcus aureus strain NRS70. In this initial test, zone inhibition measurements 
for Sb(Ph)4(TDCO) were omitted as the PBS buffer was contaminated, results for this 
compounds were completed in the following round of testing. Figures 54-56 represent the first 
triplicate set of inhibition zone measurements for antimicrobial activity determination. In the 
case of Sb(Ph)4(ACO), it showed a trend against all strains of increased clearance zone inhibition 
as Sb(V) cyanoximate concentration increased (Figure 54). This can be said for the 
Sb(Ph)4(ECO) monomer for S. aureus and E .coli, but did not keep that trend against P. 
aeruginosa. Finally, Sb(Ph)4(TCO) demonstrated the decent inhibition against S. aureus, but no 
inhibition at all against P. aeruginosa and E. coli. Full worksheets including statistical analysis 
of the first round of susceptibility tests can be found in Appendix D-1 to D-3. 
 
 
Figure 54. Round 1 of Inhibition zone measurements of Sb(Ph)4(ACO) against microbes. 
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Figure 55. Round 1 of Inhibition zone measurements of Sb(Ph)4(ECO) against microbes. 
 
Figure 56. Round 1 of inhibition zone measurements of Sb(Ph)4(TCO) against microbes. 
 
           V.6.2. Second set of inhibition measurements. The second round of susceptibility tests 
added a new compound, a control Sb(Ph)Br (labeled as CC# in Figure 57), and restarted 
measurements with Sb(Ph)4(TDCO) due to previous contamination of PBS in the experiment. 
Each were run in triplicate at three different concentrations. The measurements can be found in 
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Figure 57. Essentially the same outcome occurred for Sb(Ph)4(ACO), Sb(Ph)4(ECO), and 
Sb(Ph)4(TCO) as the first round of tests. For Sb(Ph)4Br there was no inhibition against P. 
aeruginosa, and some inhibition against E. coli..  An interesting outcome is the inhibition zone 
of Sb(Ph)4Br with respect to S. aureus. A possible reason for this outcome could be due to an 
ionic halogen exposure to gram-positive bacteria which has less intrinsic defenses as gram-
positive bacteria lack a second cell membrane. A similar result with the first round, both of the 
thioamide cyanoximates, Sb(Ph)4(TCO) and Sb(Ph)4(TDCO), only had antimicrobial effect 
against the gram-positive S. aureus . The result of zone inhibition being present in only the gram-
positive S. aureus might show that there an instrinsic antimicrobial resistance against thioamide-
containing organoantimony cyanoximates, though more testing needs to be conducted. Raw data 
and statistical analysis of this data can be found in under Appendix D-4 
           V.6.3. Initial broth dilution MIC tests. Initial compounds selected for antimicrobial 
MIC tests were: Sb(Ph)4(MCO), H(MCO), H(ECO), and Na[H(ACO)2]. The goal of this testing 
was to determine if free cyanoximes had any effect on inhibition cell growth of the same strains 
tested in the inhibition zone measurements, as well as testing out an organoantimony(V) 
cyanoximate. As these compounds were dissolved in DMSO, it must be reiterated that the 
organic solvent has inhibition effects already once concentrations reach above 5% (Appendix D-
1). This inhibition concentration with DMSO would require 200 μg/mL for P. aeruginosa and 
250 μg/mL for both E. coli and S. aureus.  
Results of the antimicrobial MIC assays are shown in Figure 58 and 59. It is evident in MIC at 
both the 6 and 24 hours marks that Sb(Ph)4(MCO) had inhibition of cell growth before the 
DMSO inhibition level at 5%. Sb(Ph)4(MCO) had a definite antimicrobial effect on E. coli and S. 
aureus at 200 μg/mL concentration. Compared with P. aeruginosa, some inhibition was seen 
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once concentration was increased. Switching over to the free cyanoximes, the inhibition of cells 
was clearly due to DMSO concentration increasing as the interval from switching to a 
concentration of zero to 100 μg/mL demonstrated negligible decrease of OD600, therefore an 
indirect method to quantify microbe concentration. What is a significant factor to free 
cyanoximes not contributing towards antimicrobial activity is at 6 hours for P. aeruginosa for all 
protonated ligands is the increase of concentration from zero to 100 μg/mL causing an increase 
of microbe concentration.  Free cyanoximes tested had no effect against the strain PAO1 of P. 
aeruginosa. As for the other strains, the increasing free cyanoxime concentration had little to no 
effect on inhibition of microbe growth. 
 
V.7. Antifungal Studies 
           These assays were performed by Dr. Karen Wozinak and her research group. Sample 
preparation was exactly the same as MIC and susceptibility assays for antimicrobial studies. 
Inhibition zone measurements were completed in two parts and both will be discussed, along 
with reconstituted MIC assays.  
           V.7.1. Kirby-Bauer disk assays. Initial antifungal studies tested a control (blank cotton 
disk), Sb(Ph)4(ECO), Sb(Ph)4(ACO), Sb(Ph)4(TCO), and Sb(Ph)4(TDCO) against two strains of 
fungi: Cryptococcus neoformans and Candida albicans. Disks were prepared at three different 
concentrations and run in triplicate. Antifungal disk assays can be seen in Figure 60. A general 
trend with Sb(Ph)4(ACO), Sb(Ph)4(ECO), Sb(Ph)4(TDCO) against Cryptococcus neoformans is 
that increasing concentration has a positive effect of increasing size of inhibition zone, though 
for Sb(Ph)4(TDCO), the zone of inhibition was lower at all concentrations when compared to 
Sb(Ph)4(TCO) which had an opposite trend than the previous three compounds. With regard to 
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Candida albicans against our copounds, it appeared that Sb(Ph)4(ECO) had some form of 
antifungal activity, but all other compounds were not promising in that field.   
           V.7.2. MIC antifungal activity assay. MIC assays were conducted to show a 
comparative study of free cyanoximes with an organoantimony(V) cyanoximate against the same 
fungi strains as disk assays. Results of initial MIC assay in singlet can be seen in Figure 61. Any 
MICs at 100 μg/mL signified no inhibitory effects. This was the maximum concentration that the 
lab could identify with their equipment. Considering the results of each free cyanoxime, it is a 
clear statement that free 
cyanoximes have no antifungal activity. On the other hand, when the MCO- cyanoxime anion 
was coordinated to organoantimony(V) a clear showing of inhibition was recorded. A second run 
of tests was performed with essentially the same results as the initial MIC assay, except a lower 
MIC in the case of Cryptococcus neoformans (Figure 62). Regardless, if one thing is evident, 
further studies must be conducted to solidify the practicality of using organoantimony (V) 
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Summary of susceptibility tests with discs
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MIC after 24 hours of incubation
0 µg/ml 100 µg/ml 150 µg/ml 200 µg/ml 250 µg/ml 300 µg/ml 350 µg/ml 400 µg/ml 450 µg/ml 500 µg/ml
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Figure 60. Results of initial disk assays for antifungal activity studies. 
 
 
Figure 61. Results of initial MIC assays for antifungal activity studies. 





























































































































































































































































VI.    CONCLUSIONS AND SUMMARY 
           This research project has been carried out within the last three years. As the result of 
conducted investigation all outlined goals at the beginning of this thesis were accomplished. More 
specific outcomes are presented as chemical and biological results and listed below.  
Chemical part: 
 Several protonated HL cyanoximes, their Ag(I) (for MCO-) and Tl(I) (for TCO-, TDCO- 
ligands) derivatives have been synthesized and characterized for the purpose of preparation 
of new organoantimony(V) cyanoximate-containing compounds. 
 
 Synthesized organoantimony(V) cyanoximates were characterized by elemental analysis, 
TG/DSC analysis, FT-IR, 13C{1H} NMR and, in some cases, variable temperature UV-
visible spectroscopy.  
 
 Eight new crystal structures of organoantimony(V) cyanoximates were determined and one 
previously described in our group compound re-examined second time at low temperature 
to improve quality of its data. Eight complexes represent mononuclear molecular 
organometallic compounds and one is a linear -oxo dimer with trans-positioned 
cyanoxime moieties (case with ECO- ligand).  
 
 Two polymorphs were observed in the Sb(Ph)4(TCO) system and their origin relates to the 
crystallization method. Three structures out of nine contain multiple crystallographically 
independent molecules in the asymmetric unit (ASU): two in structures of Sb(Ph)4(ECO) 
and Sb(Ph)4(MCO) and eight in the structure of second polymorph of Sb(Ph)4(TCO).  
 
 In all nine oganoantimony(V) cyanoximates central atom is in pentavalent state and has 
distorted trigonal bipyramid environment comprising of four carbon atoms of the phenyl 
groups and one oxygen atom of the cyanoxime anion bound to a Sb(V) center in a 
monodentate manner. 
 
 All synthesized compounds are well soluble in common organic solvents and poorly 
soluble in water and aqueous buffers. All solutions in organic solvents are stable over time 




 Two kinds of antimicrobial activity tests were carried out for selected new 
organoantimony(V) cyanoximates: 1) based on paper disks with solid compounds on solid 
media determination of zone of inhibition, and 2) determination of the minimal inhibitory 
concentration (MIC) in solutions of compounds.  
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 Five Sb(V) cyanoximates: Sb(Ph)4(ACO), monomeric Sb(Ph)4(ECO), Sb(Ph)4(MCO), 
Sb(Ph)4(TCO), and Sb(Ph)4(TDCO) were selected at the beginning of antimicrobial and 
antifungal studies via paper disk susceptibility and MIC assays. The rational for choices 
were: a) ACO-, ECO- and MCO- cyanoxime anions possess some water solubility and are 
rich on oxygen donor atoms; b) TCO- and TDCO- are thioamides. Therefore, there is a 
chance of making structure-activity-relationship (SAR) comparing analogous oxo- and 
thio- cyanoximes. The control compound was the initial Sb(Ph)4Br compound without 
cyanoximes. Also, pure ligands such as H(MCO), H(ECO) and Na{H(ACO)}2 without Sb-
atoms were used as a second set of controls.  
 
 Antimicrobial paper disk studies indicated that Sb(Ph)4(ACO), Sb(Ph)4(ECO), have 
significant antimicrobial effect against all three employed strains: two gram-negative 
Escherichia coli strain S17 and Pseudomonas aeruginosa strain PAO1, alongside a single 
gram-positive Methicillin-resistant Staphylococcus aureus strain NRS70.  
 
 Sb(Ph)4(TCO) and Sb(Ph)4(TDCO) had significant effects on the gram- positive 
Methicillin-resistant Staphylococcus aureus strain NRS70, but essentially no antimicrobial 
activity for gram-negative strains used, which we found to be very interesting. 
 
 MIC assay results indicated that free cyanoximes have no antimicrobial effect, but the 
DMSO solvent used in these assays contributed to the inhibition factor to the MIC assay 
on cell cultures in solutions. 
 
 Antifungal disk assays were studied with the compounds Sb(Ph)4(ACO), Sb(Ph)4(ECO), 
Sb(Ph)4(TCO), and Sb(Ph)4(TDCO) against the fungi of Cryptococcus neoformans and 
Candida albicans strains. Disk assays concluded that Sb(Ph)4(ECO) was effective against 
Cryptococcus neoformans and Candida albicans in a positive trend. Sb(Ph)4(TCO) was the 
next contributor towards antifungal activity against both strains. Sb(Ph)4(ACO) and 
Sb(Ph)4(TDCO) were only effective at inhibition of Cryptococcus neoformans, while those 
compounds did not contribute to any inhibition towards Candida albicans. 
 
 Antifungal MIC assays were conducted on the same strains as the disks assays and used 
the same Sb(V) cyanoximate Sb(Ph)4(MCO) along with the free ligands H(MCO), 
H(ECO), and Na[H(ACO)2]. Results indicated that the free, uncomplexed cyanoximes had 
zero effect on antifungal activity in both replicas of the experiment. On the other hand, 
Sb(Ph)4(MCO) had shown MIC levels ranging from 10 - 50 μg/mL, proving there is 







VII.    FUTURE WORK 
 
           The future of using organoantimony(V) cyanoximates as a novel treatment against drug-
resistant microbes and fungi is very hopeful. In terms of crystal structures, Sb(Ph)4(TDCO) can be 
determined. Further antimicrobial and antifungal testing is required to understand how practical 
Sb(V) cyanoximates are for treatment. Tests would include: a larger variety of ligands both free 
and Sb(V) coordinated. Testing with the heterocyclic cyanoximes would also be beneficial as 
expanding the library of biologically active compounds is useful.  Progressing with cytotoxicity 
studies of Sb(V) cyanoximates is in the future, and its result will be detrimental to the development 
of this promising, new treatment. Given the positive results of certain monodentate ligands in this 
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Appendix A.  Instrumentation of TG/DSC Analysis 
 
Appendix A-1. A – general view of the thermal analyzer showing blow torch used for crucible 
cleaning and tools; B – cleaning of alumina crucible with flame; C – opened furnace view showing 




Appendix B. Traces of TG/DSC analyses. 
 
Appendix B-1. TG/DSC traces for a sample of SbPh4(2PCO) showing compounds melting with 




Appendix B-2. TG/DSC traces for a sample of SbPh4(4PCO) showing compounds melting 
followed by decomposition. 
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Appendix B-3. TG/DSC traces for a sample of SbPh4(ACO) showing compounds melting with 




Appendix B-4. TG/DSC traces for a sample of SbPh4(TCO) showing compounds melting with 





Appendix B-5. TG/DSC traces for a sample of SbPh4(MCO) (in usable range) showing 




Appendix B-6. TG/DSC traces for a sample of SbPh4(TDCO) (in usable range) showing 











Appendix C. Crystal checkCIF Reports for Studied Complexes 
 
Appendix C-1. checkCIF-reports for Sb(Ph)4(ACO). 
checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) Sb-pH4-ACO 
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW 
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE 
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE. 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0034 A Wavelength=0.71073 
Cell: a=14.8336(8) b=9.9060(6) c=17.3977(10) 
 alpha=90 beta=112.713(1) gamma=90 
Temperature: 120 K   
 Calculated Reported 
Volume 2358.2(2) 2358.2(2) 
Space group P 21/c P 21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C27 H22 N3 O2 Sb C27 H22 N3 O2 Sb 
Sum formula C27 H22 N3 O2 Sb C27 H22 N3 O2 Sb 
Mr 542.24 542.22 
Dx,g cm-3 1.527 1.527 
Z 4 4 
Mu (mm-1) 1.199 1.199 
F000 1088.0 1088.0 
F000' 1086.02  
h,k,lmax 22,15,26 22,15,26 
Nref 8912 8465 
Tmin,Tmax 0.864,0.901 0.648,0.953 
Tmin' 0.839  
Correction method= # Reported T Limits: 
Tmin=0.648 Tmax=0.953 AbsCorr = NUMERICAL 
 





S = 1.172 Npar= 386 
113 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level B 
PLAT919_ALERT_3_B Reflection # Likely Affected by the Beamstop ...          1 
Check  
PLAT934_ALERT_3_B Number of (Iobs-Icalc)/Sigma(W) > 10 Outliers ..          8 
Check  
 
Alert level C 
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       2.71 
Report 
PLAT420_ALERT_2_C D-H Without Acceptor       N3       --H2N3     .     Please 
Check  
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  2.26A   From C5              1.62 
eA-3   
 
Alert level G 
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.         20 
Note   
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........          2 
Note   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600        447 
Note   
PLAT941_ALERT_3_G Average HKL Measurement Multiplicity ...........        4.5 
Low    
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          4 
Info   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   2 ALERT level B = A potentially serious problem, consider carefully 
   3 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
   7 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   5 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   3 ALERT type 3 Indicator that the structure quality may be low 
   3 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
 
PLATON version of 04/06/2020; check.def file version of 02/06/2020 




Appendix C-2. checkCIF-reports for Sb(Ph)4(2PCO). 
____________________________________________________ 
checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) Sb-Ph4-2pco 
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW 
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE 
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE. 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0044 A Wavelength=0.71073 
Cell: a=12.6027(8) b=14.4415(10) c=14.6694(10) 
 alpha=90 beta=104.9644(10) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 2579.3(3) 2579.3(3) 
Space group P 21/n P 21/n 
Hall group -P 2yn -P 2yn 
Moiety formula C31 H24 N3 O Sb C31 H24 N3 O Sb 
Sum formula C31 H24 N3 O Sb C31 H24 N3 O Sb 
Mr 576.29 576.28 
Dx,g cm-3 1.484 1.484 
Z 4 4 
Mu (mm-1) 1.098 1.098 
F000 1160.0 1160.0 
F000' 1158.02  
h,k,lmax 15,18,18 15,18,18 
Nref 5461 5458 
Tmin,Tmax 0.846,0.912 0.872,0.949 
Tmin' 0.829  
Correction method= # Reported T Limits: 
Tmin=0.872 Tmax=0.949 AbsCorr = NUMERICAL 
 





S = 1.039 Npar= 421 
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The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       3.47 
Report 
PLAT245_ALERT_2_C U(iso) H7        Smaller than U(eq) C7        by      0.013 
Ang**2 
PLAT245_ALERT_2_C U(iso) H24       Smaller than U(eq) C24       by      0.012 
Ang**2 
PLAT350_ALERT_3_C Short  C-H (X0.96,N1.08A)  C22      - H22      .       0.84 
Ang.   
PLAT975_ALERT_2_C Check Calcd Resid. Dens.  1.06A   From O1              0.43 
eA-3   
 
Alert level G 
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.         24 
Note   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600          3 
Note   
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          7 
Info   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   5 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
   5 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   6 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   1 ALERT type 3 Indicator that the structure quality may be low 
   2 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
 
PLATON version of 04/06/2020; check.def file version of 02/06/2020 




Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 


















Appendix C-3. checkCIF-reports for Sb(Ph)4(3PCO). 
 
 
Structure factors have been supplied for datablock(s) Sb-Ph4-3PCO 
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW 
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE 
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE. 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0036 A Wavelength=0.71073 
Cell: a=10.0228(4) b=10.4598(4) c=13.8258(5) 
 alpha=69.324(1) beta=72.086(1) gamma=83.971(1) 
Temperature: 296 K   
 Calculated Reported 
Volume 1290.34(9) 1290.34(9) 
Space group P -1 P -1 
Hall group -P 1 -P 1 
Moiety formula C31 H24 N3 O Sb C31 H24 N3 O Sb 
Sum formula C31 H24 N3 O Sb C31 H24 N3 O Sb 
Mr 576.29 576.28 
Dx,g cm-3 1.483 1.483 
Z 2 2 
Mu (mm-1) 1.098 1.098 
F000 580.0 580.0 
F000' 579.01  
h,k,lmax 13,13,18 13,13,18 
Nref 6224 6218 
Tmin,Tmax 0.822,0.897 0.697,0.747 
Tmin' 0.798  
Correction method= # Reported T Limits: 
Tmin=0.697 Tmax=0.747 AbsCorr = MULTI-SCAN 
 





S = 1.055 Npar= 421 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
118 
PLAT230_ALERT_2_C Hirshfeld Test Diff for    C11      --C12      .        6.5 
s.u.   
PLAT241_ALERT_2_C High   'MainMol' Ueq as Compared to Neighbors of         C5 
Check  
PLAT242_ALERT_2_C Low    'MainMol' Ueq as Compared to Neighbors of         C3 
Check  
PLAT350_ALERT_3_C Short  C-H (X0.96,N1.08A)  C4       - H4       .       0.83 
Ang.   
And 2 other PLAT350 Alerts 
PLAT350_ALERT_3_C Short  C-H (X0.96,N1.08A)  C12      - H12      .       0.84 
Ang.   
PLAT350_ALERT_3_C Short  C-H (X0.96,N1.08A)  C19      - H19      .       0.84 
Ang.   
PLAT911_ALERT_3_C Missing FCF Refl Between Thmin & STh/L=    0.600          2 
Report 
 
Alert level G 
PLAT154_ALERT_1_G The s.u.'s on the Cell Angles are Equal ..(Note)      0.001 
Degree 
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.         24 
Note   
PLAT230_ALERT_2_G Hirshfeld Test Diff for    C1       --C2       .        6.2 
s.u.   
PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X)  Sb1      --O1       .        6.1 
s.u.   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600          4 
Note   
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...          4 
Note   
PLAT941_ALERT_3_G Average HKL Measurement Multiplicity ...........        2.9 
Low    
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.         12 
Info   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   7 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
  10 ALERT level G = General information/check it is not something unexpected 
 
   2 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   8 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   5 ALERT type 3 Indicator that the structure quality may be low 
   2 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
 
PLATON version of 04/06/2020; check.def file version of 02/06/2020 
119 
Datablock Sb-Ph4-3PCO - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 















Appendix C-4. checkCIF-reports for Sb(Ph)4(4PCO). 
 
checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) Sb-Ph4-4PCO 
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW 
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE 
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE. 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0031 A Wavelength=0.71073 
Cell: a=15.3352(10) b=9.7848(6) c=19.6576(9) 
 alpha=90 beta=119.272(4) gamma=90 
Temperature: 120 K   
 Calculated Reported 
Volume 2573.0(3) 2573.0(3) 
Space group P 21/c P 21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C31 H24 N3 O Sb C31 H24 N3 O Sb 
Sum formula C31 H24 N3 O Sb C31 H24 N3 O Sb 
Mr 576.29 576.28 
Dx,g cm-3 1.488 1.428 
Z 4 4 
Mu (mm-1) 1.101 1.099 
F000 1160.0 1068.0 
F000' 1158.02  
h,k,lmax 23,15,30 22,14,29 
Nref 9749 9309 
Tmin,Tmax 0.730,0.803 0.683,0.880 
Tmin' 0.514  
Correction method= # Reported T Limits: 
Tmin=0.683 Tmax=0.880 AbsCorr = NUMERICAL 
 





S = 1.098 Npar= 417 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
121 
 
Alert level C 
DENSD01_ALERT_1_C  The ratio of the submitted crystal density and that 
            calculated from the formula is outside the range 0.99 <> 1.01 
            Crystal density given    =      1.428 
            Calculated crystal density =      1.488 
PLAT046_ALERT_1_C Reported Z, MW and D(calc) are Inconsistent ....      1.488 
Check  
PLAT068_ALERT_1_C Reported F000 Differs from Calcd (or Missing)...     Please 
Check  
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       2.99 
Report 
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.12A   From C21             1.73 
eA-3   
 
Alert level G 
PLAT128_ALERT_4_G Alternate Setting for Input Space Group  P21/c        P21/n 
Note   
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.         23 
Note   
PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X)  Sb1      --O1       .        5.3 
s.u.   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600        400 
Note   
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...         10 
Note   
PLAT941_ALERT_3_G Average HKL Measurement Multiplicity ...........        4.5 
Low    
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.         15 
Info   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   5 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
   9 ALERT level G = General information/check it is not something unexpected 
 
   4 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   6 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   1 ALERT type 3 Indicator that the structure quality may be low 
   3 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
PLATON version of 04/06/2020; check.def file version of 02/06/2020 




Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 


















Appendix C-5. checkCIF-reports for the Sb(Ph)4(ECO) μ-oxo-dimer. 
 
checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) Sb-Ph4-ECI-oxo-dimer 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0024 A Wavelength=0.71073 
Cell: a=9.1828(9) b=10.0829(10) c=13.4714(16) 
 alpha=111.957(1) beta=103.200(2) gamma=95.405(1) 
Temperature: 120 K   
 Calculated Reported 
Volume 1103.8(2) 1103.8(2) 
Space group P -1 P -1 
Hall group -P 1 -P 1 
Moiety formula C46 H40 N4 O7 Sb2 C46 H40 N4 O7 Sb2 
Sum formula C46 H40 N4 O7 Sb2 C46 H40 N4 O7 Sb2 
Mr 1004.34 1004.32 
Dx,g cm-3 1.511 1.511 
Z 1 1 
Mu (mm-1) 1.277 1.277 
F000 502.0 502.0 
F000' 501.02  
h,k,lmax 13,14,19 13,14,19 
Nref 6741 6688 
Tmin,Tmax 0.712,0.795 0.824,1.000 
Tmin' 0.282  
Correction method= # Reported T Limits: 
Tmin=0.824 Tmax=1.000 AbsCorr = NUMERICAL 
 





S = 1.079 Npar= 348 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
124 
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       2.52 
Report 
 
Alert level G 
PLAT063_ALERT_4_G Crystal Size Possibly too Large for Beam Size ..       0.98 
mm     
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.         20 
Note   
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........          1 
Note   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600         52 
Note   
PLAT941_ALERT_3_G Average HKL Measurement Multiplicity ...........        2.6 
Low    
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.         16 
Info   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   1 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
   8 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   3 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   1 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 




PLATON version of 04/06/2020; check.def file version of 02/06/2020 




Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 

















Appendix C-6. checkCIF-reports for Sb(Ph)4(ECO) monomer. 
 
checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) Sb-Ph4-ECO-monomer 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0080 A Wavelength=0.71073 
Cell: a=9.7871(6) b=14.9208(9) c=17.6984(11) 
 alpha=90 beta=94.613(1) gamma=90 
Temperature: 120 K   
 Calculated Reported 
Volume 2576.2(3) 2576.1(3) 
Space group P n P n 
Hall group P -2yac P -2yac 
Moiety formula C29 H25 N2 O3 Sb C29 H25 N2 O3 Sb 
Sum formula C29 H25 N2 O3 Sb C29 H25 N2 O3 Sb 
Mr 571.27 571.26 
Dx,g cm-3 1.473 1.473 
Z 4 4 
Mu (mm-1) 1.103 1.103 
F000 1152.0 1152.0 
F000' 1150.07  
h,k,lmax 15,22,27 14,22,26 
Nref 19496[ 9759] 9092 
Tmin,Tmax 0.815,0.849 0.653,0.747 
Tmin' 0.791  
Correction method= # Reported T Limits: 
Tmin=0.653 Tmax=0.747 AbsCorr = MULTI-SCAN 
 
Data completeness= 





S = 1.193 Npar= 654 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
127 
STRVA01_ALERT_4_C           Flack test results are ambiguous. 
           From the CIF: _refine_ls_abs_structure_Flack    0.530 
           From the CIF: _refine_ls_abs_structure_Flack_su    0.040 
PLAT220_ALERT_2_C NonSolvent Resd 1  C   Ueq(max) / Ueq(min) Range        3.2 
Ratio  
PLAT220_ALERT_2_C NonSolvent Resd 2  C   Ueq(max) / Ueq(min) Range        3.3 
Ratio  
PLAT222_ALERT_3_C NonSolvent Resd 1  H   Uiso(max)/Uiso(min) Range        6.6 
Ratio  
PLAT342_ALERT_3_C Low Bond Precision on  C-C Bonds ...............    0.00802 
Ang.   
PLAT907_ALERT_2_C Flack x > 0.5, Structure Needs to be Inverted? .       0.53 
Check  
PLAT914_ALERT_3_C No Bijvoet Pairs in FCF for Non-centro Structure     Please 
Check  
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  0.85A   From Sb1B            1.73 
eA-3   
And 2 other PLAT971 Alerts 
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.30A   From C18B            1.51 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  0.64A   From Sb1A            1.51 
eA-3   
PLAT977_ALERT_2_C Check Negative Difference Density on H13A             -0.41 
eA-3   
And 2 other PLAT977 Alerts 
PLAT977_ALERT_2_C Check Negative Difference Density on H16B             -0.32 
eA-3   
PLAT977_ALERT_2_C Check Negative Difference Density on H26A             -0.35 
eA-3   
 
Alert level G 
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT  Unusually Large       5.57 
Why ?  
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.          5 
Note   
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........         10 
Note   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600        656 
Note   
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...          5 
Note   
PLAT941_ALERT_3_G Average HKL Measurement Multiplicity ...........        1.0 
Low    
PLAT961_ALERT_5_G Dataset Contains no Negative Intensities .......     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          0 
Info   




   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
  13 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
  10 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
  12 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   4 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
 
 
PLATON version of 04/06/2020; check.def file version of 02/06/2020 
Datablock Sb-Ph4-ECO-monomer - ellipsoid plot 
 
Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 
Test a new CIF entry 
129 
Appendix C-7. checkCIF-reports for Sb(Ph)4(MCO). 
 
checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) Sb-Ph4-MCO 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0065 A Wavelength=0.71073 
Cell: a=17.6451(4) b=10.8777(3) c=28.3876(7) 
 alpha=90 beta=94.836(1) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 5429.3(2) 5429.3(2) 
Space group P 21/c P 21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C31 H28 N3 O3 Sb C31 H28 N3 O3 Sb 
Sum formula C31 H28 N3 O3 Sb C31 H28 N3 O3 Sb 
Mr 612.32 612.31 
Dx,g cm-3 1.498 1.498 
Z 8 8 
Mu (mm-1) 1.054 1.054 
F000 2480.0 2480.0 
F000' 2476.19  
h,k,lmax 22,13,35 22,13,35 
Nref 11273 11251 
Tmin,Tmax 0.863,0.881 0.689,0.745 
Tmin' 0.863  
Correction method= # Reported T Limits: 
Tmin=0.689 Tmax=0.745 AbsCorr = MULTI-SCAN 
 





S = 1.114 Npar= 750 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
130 
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       3.19 
Report 
PLAT222_ALERT_3_C NonSolvent Resd 2  H   Uiso(max)/Uiso(min) Range        7.7 
Ratio  
PLAT245_ALERT_2_C U(iso) H28A      Smaller than U(eq) C28A      by      0.017 
Ang**2 
And 3 other PLAT245 Alerts 
PLAT245_ALERT_2_C U(iso) H13B      Smaller than U(eq) C13B      by      0.012 
Ang**2 
PLAT245_ALERT_2_C U(iso) H21B      Smaller than U(eq) C21B      by      0.014 
Ang**2 
PLAT245_ALERT_2_C U(iso) H30B      Smaller than U(eq) C30B      by      0.012 
Ang**2 
PLAT906_ALERT_3_C Large K Value in the Analysis of Variance ......      4.570 
Check  
PLAT911_ALERT_3_C Missing FCF Refl Between Thmin & STh/L=    0.600          9 
Report 
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.05A   From C26B            1.94 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.18A   From Sb1A            1.65 
eA-3   
PLAT975_ALERT_2_C Check Calcd Resid. Dens.  0.81A   From O1A             0.57 
eA-3   
 
Alert level G 
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT  Unusually Large      14.34 
Why ?  
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.         16 
Note   
PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X)  Sb1A     --O1A      .        5.3 
s.u.   
PLAT398_ALERT_2_G Deviating  C-O-C    Angle From 120 for O3B            109.9 
Degree 
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........         16 
Note   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600         15 
Note   
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...         10 
Note   
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          2 
Info   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
  11 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
  10 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
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  14 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   3 ALERT type 3 Indicator that the structure quality may be low 
   3 ALERT type 4 Improvement, methodology, query or suggestion 
   0 ALERT type 5 Informative message, check 
 
 
PLATON version of 04/06/2020; check.def file version of 02/06/2020 
Datablock Sb-Ph4-MCO - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 





Appendix C-8. checkCIF-reports for Sb(Ph)4(TCO) polymorph 1. 
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checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) done_Sb-Ph4-TCO-
polymorph-1 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0045 A Wavelength=0.71073 
Cell: a=14.6709(7) b=9.8468(5) c=18.3414(9) 
 alpha=90 beta=111.994(1) gamma=90 
Temperature: 120 K   
 Calculated Reported 
Volume 2456.8(2) 2456.8(2) 
Space group P 21/c P 21/c 
Hall group -P 2ybc -P 2ybc 
Moiety formula C27 H21 N3 O S Sb C27 H21 N3 O S Sb 
Sum formula C27 H21 N3 O S Sb C27 H21 N3 O S Sb 
Mr 557.29 557.28 
Dx,g cm-3 1.507 1.507 
Z 4 4 
Mu (mm-1) 1.232 1.232 
F000 1116.0 1116.0 
F000' 1114.48  
h,k,lmax 18,12,23 18,12,23 
Nref 5478 5476 
Tmin,Tmax 0.814,0.840 0.894,0.931 
Tmin' 0.814  
Correction method= # Reported T Limits: 
Tmin=0.894 Tmax=0.931 AbsCorr = NUMERICAL 
 





S = 1.033 Npar= 391 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
Click on the hyperlinks for more details of the test. 
 
Alert level C 
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PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       2.03 
Report 
PLAT420_ALERT_2_C D-H Without Acceptor       N3       --H3B      .     Please 
Check  
PLAT973_ALERT_2_C Check Calcd Positive Resid. Density on       Sb1       1.03 
eA-3   
PLAT975_ALERT_2_C Check Calcd Resid. Dens.  0.84A   From C8              0.68 
eA-3   
 
Alert level G 
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms ..............          4 
Report 
PLAT164_ALERT_4_G Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.         14 
Note   
PLAT171_ALERT_4_G The CIF-Embedded .res File Contains EADP Records          6 
Report 
PLAT301_ALERT_3_G Main Residue  Disorder ..............(Resd  1  )        24% 
Note   
PLAT343_ALERT_2_G Unusual sp?      Angle Range in Main Residue for         C8 
Check  
PLAT432_ALERT_2_G Short Inter X...Y Contact  C18      ..N2A              2.93 
Ang.   
                                           1-x,-1/2+y,1/2-z  =      2_645 
Check  
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........          2 
Note   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT910_ALERT_3_G Missing # of FCF Reflection(s) Below Theta(Min).          1 
Note   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600          2 
Note   
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...          1 
Note   
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          2 
Info   
 
   0 ALERT level A = Most likely a serious problem - resolve or explain 
   0 ALERT level B = A potentially serious problem, consider carefully 
   4 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
  12 ALERT level G = General information/check it is not something unexpected 
 
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
   8 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   2 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 
   1 ALERT type 5 Informative message, check 
 
PLATON version of 04/06/2020; check.def file version of 02/06/2020 




Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 

















Appendix C-9. checkCIF-reports for Sb(Ph)4(TCO) polymorph 2. 
 
checkCIF/PLATON (basic structural check) 
 
Structure factors have been supplied for datablock(s) Sb-Ph4-TCO_polymorph-2 
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW 
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE 
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE. 
No syntax errors found.                               CIF dictionary 
Please wait while processing ....                     Interpreting this 
report 




Bond precision: C-C = 0.0152 A Wavelength=0.71073 
Cell: a=24.517(4) b=24.448(4) c=32.958(5) 
 alpha=90 beta=101.670(2) gamma=90 
Temperature: 100 K   
 Calculated Reported 
Volume 19346(5) 19346(5) 
Space group C c C c 
Hall group C -2yc C -2yc 
Moiety formula C27 H22 N3 O S Sb C27 H22 N3 O S Sb 
Sum formula C27 H22 N3 O S Sb C216 H176 N24 O8 S8 Sb8 
Mr 558.30 4466.28 
Dx,g cm-3 1.533 1.533 
Z 32 4 
Mu (mm-1) 1.252 1.252 
F000 8960.0 8960.0 
F000' 8947.83  
h,k,lmax 33,33,45 33,33,45 
Nref 53786[ 26901] 49604 
Tmin,Tmax 0.837,0.915 0.626,0.746 
Tmin' 0.837  
Correction method= # Reported T Limits: 
Tmin=0.626 Tmax=0.746 AbsCorr = MULTI-SCAN 
 
Data completeness= 





S = 1.047 Npar= 2379 
 
The following ALERTS were generated. Each ALERT has the format 
       test-name_ALERT_alert-type_alert-level. 
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Click on the hyperlinks for more details of the test. 
 
Alert level A 
PLAT213_ALERT_2_A Atom C24D            has ADP max/min Ratio .....        5.3 
prolat 
PLAT213_ALERT_2_A Atom C18F            has ADP max/min Ratio .....        5.9 
oblate 
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.59A   From N1D             5.81 
eA-3   
And 7 other PLAT971 Alerts 
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.56A   From C21B            5.72 
eA-3   
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.61A   From C17Q            5.42 
eA-3   
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.56A   From N1C             5.25 
eA-3   
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.49A   From C11E            5.21 
eA-3   
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.51A   From N1F             5.12 
eA-3   
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.58A   From C17A            4.91 
eA-3   
PLAT971_ALERT_2_A Check Calcd Resid. Dens.  1.53A   From C11H            4.84 
eA-3   
 
Alert level B 
PLAT097_ALERT_2_B Large Reported Max.  (Positive) Residual Density       5.68 
eA-3   
PLAT971_ALERT_2_B Check Calcd Resid. Dens.  1.66A   From C13E            2.89 
eA-3   
And 3 other PLAT971 Alerts 
PLAT971_ALERT_2_B Check Calcd Resid. Dens.  1.80A   From C19A            2.88 
eA-3   
PLAT971_ALERT_2_B Check Calcd Resid. Dens.  1.79A   From C19Q            2.73 
eA-3   
PLAT971_ALERT_2_B Check Calcd Resid. Dens.  1.80A   From C25D            2.54 
eA-3   
 
Alert level C 
DIFMX02_ALERT_1_C  The maximum difference density is > 0.1*ZMAX*0.75 
            The relevant atom site should be identified. 
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....       2.76 
Report 
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PLAT213_ALERT_2_C Atom C6C             has ADP max/min Ratio .....        3.4 
prolat 
PLAT234_ALERT_4_C Large Hirshfeld Difference C19B     --C20B     .       0.18 
Ang.   
PLAT234_ALERT_4_C Large Hirshfeld Difference C6C      --C7C      .       0.17 
Ang.   
PLAT342_ALERT_3_C Low Bond Precision on  C-C Bonds ...............    0.01521 
Ang.   
PLAT911_ALERT_3_C Missing FCF Refl Between Thmin & STh/L=    0.600         14 
Report 
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.76A   From C13H            2.39 
eA-3   
And 8 other PLAT971 Alerts 
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.78A   From C19B            2.27 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.67A   From C19F            2.15 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.66A   From C7C             2.04 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.95A   From C2A             1.72 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.93A   From C2E             1.70 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.82A   From C2H             1.69 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.80A   From C2Q             1.68 
eA-3   
PLAT971_ALERT_2_C Check Calcd Resid. Dens.  1.93A   From C2F             1.54 
eA-3   
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.60A   From Sb1B           -1.96 
eA-3   
And 8 other PLAT972 Alerts 
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.74A   From Sb1C           -1.85 
eA-3   
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.72A   From Sb1D           -1.83 
eA-3   
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.75A   From Sb1Q           -1.71 
eA-3   
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.78A   From Sb1F           -1.67 
eA-3   
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PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.61A   From Sb1E           -1.58 
eA-3   
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.61A   From Sb1F           -1.55 
eA-3   
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.78A   From Sb1C           -1.53 
eA-3   
PLAT972_ALERT_2_C Check Calcd Resid. Dens.  0.77A   From Sb1B           -1.51 
eA-3   
PLAT977_ALERT_2_C Check Negative Difference Density on H9H              -0.31 
eA-3   
PLAT977_ALERT_2_C Check Negative Difference Density on H23E             -0.35 
eA-3   
 
Alert level G 
FORMU01_ALERT_1_G  There is a discrepancy between the atom counts in the 
            _chemical_formula_sum and _chemical_formula_moiety. This is 
            usually due to the moiety formula being in the wrong format. 
            Atom count from _chemical_formula_sum:   C216 H176 N24 O8 S8 Sb8 
            Atom count from _chemical_formula_moiety:C27 H22 N3 O1 S1 Sb1 
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms ..............         16 
Report 
PLAT045_ALERT_1_G Calculated and Reported Z Differ by a Factor ...       8.00 
Check  
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT  Unusually Large     137.89 
Why ?  
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........         16 
Note   
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .     Please 
Do !   
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L=  0.600       1520 
Note   
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...         15 
Note   
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged     Please 
Check  
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.          0 
Info   
PLAT992_ALERT_5_G Repd & Actual _reflns_number_gt Values Differ by          2 
Check  
 
  10 ALERT level A = Most likely a serious problem - resolve or explain 
   5 ALERT level B = A potentially serious problem, consider carefully 
  27 ALERT level C = Check. Ensure it is not caused by an omission or 
oversight 
  11 ALERT level G = General information/check it is not something unexpected 
 
   4 ALERT type 1 CIF construction/syntax error, inconsistent or missing data 
  41 ALERT type 2 Indicator that the structure model may be wrong or 
deficient 
   2 ALERT type 3 Indicator that the structure quality may be low 
   4 ALERT type 4 Improvement, methodology, query or suggestion 
   2 ALERT type 5 Informative message, check 
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PLATON version of 04/06/2020; check.def file version of 02/06/2020 
Datablock Sb-Ph4-TCO_polymorph-2 - ellipsoid plot 
 
 
Download CIF editor (publCIF) from the IUCr 
Download CIF editor (enCIFer) from the CCDC 
















Appendix D-1. Raw data and statistical analysis of Sb(Ph)4(ACO) in the first round of inhibition zone measurements.
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Appendix D-2. Raw data and statistical analysis of Sb(Ph)4(ECO) in the first round of inhibition zone measurements.
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Appendix D-3. Raw data and statistical analysis of Sb(Ph)4(TCO) in the first round of inhibition zone measurements.
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Appendix D-4. Statistical analysis of the second round of inhibition zone measurements for antimicrobial testing. 
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